NZ543923A - Pho3-18 for a theraputic use, particulary in bacterial infection. - Google Patents

Abstract

Disclosed is the use of Pho3-18 (SEQ ID 21) in the treatment of Group B Streptococcus and other infections. The protein, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines to immunise a patient against microbial infection.

Description

New Zealand Paient Spedficaiion for Paient Number 543923 543921 ■m w NEW ZEALAND PATENTS ACT, 1953 Divided out of New Zealand Specification No. 535122 dated 22 December 1999 COMPLETE SPECIFICATION GENE AND PROTEINS, AND THEIR USE No: Date: We, MICROSCIENCE LIMITED, 545 Eskdale Road, Winnersh Triangle, Wokingham, Berkshire RG41 5TU, United Kingdom, do hereby declare the invention for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement: (followed by page la) - 2 DEC 2005 IIICEJVED la (followed by page 2) GENES AND PROTEINS. AND THEIR USE This is a divisional of New Zealand Specification No. 535122, which in turn is a divisional of New Zealand Specification No. 526879, which in turn is a divisional of New Zealand Specification No. 512297.

Field of the Invention This invention relates to the identification of 5 bacterial 9eneis and proteins, and their use. More particularly, it relates to their use in therapy, for immunisation and in screening for drugs.

Background to the Invention Group B Streptococcus (GBS), also known as 10 Streptococcus agalactiae, is the causative agent of various conditions. In particular,. QBS causes: Early onset neonatal Infection, This infection usually begins In utero and causes severe septicaemia and pneumonia in infants, which is. 15 lethal if untreated and even with treatment is associated,-with a 10-20% mortality rate.

Late onset neonatal infection.

This infection occurs in the period shortly after birth until about 3 months of age. It causes a 20 septicaemia, which is complicated by meningitis in 90% of cases. Other focal infections also occur including osteomyelitis, septic arthritis* abscesses and endopthalmitis.

Adult infections.

These appear to be increasingly common and occur most frequently in women who have just delivered a baby, the elderly and the immunocompromised. They are characterised by septicaemia and focal infections including osteomyelitis, septic arthritis, abscesses and 30 endopthalmitis.

Urinary tract infections.

GBS is a cause of urinary tract infections and in pregnancy accounts for about 10% of all infections. Veterinary infections.

GBS causes chronic mastitis in cows. This, in turn, leads to reduced milk production and is therefore of considerable economic importance. 2 GBS infections can be treated with antibiotics.

However, immunization is preferable. It is therefore desirable to develop an immunogen that could be used in a therapeutically-effective vaccine.

It is an object of the invention to go some way towards fulfilling this desideratum and/or to provide the public with a useful choice. summary of the Invention The present invention is based on the identification of a series of genes in GBS, and also related organisms, the products of which may be localised on the outer surface of the organism and therefore may be used as a tar-get for iswuno-ther apy.

Hie present invention is directed to a peptide having an amino acid sequence of SEQ ID NO: 21 (pho3-18) or a homologue having at least 70% sequence identity thereto, for therapeutic use.

Also described is a peptide comprising a sequence selected from the group of sequences identified herein as SEQ ID NOs: 2, 4, 6, 8,10,11, 17, 19, 25, 27, 29, 31, 33 and 35, or a homologue having at least 70% sequence similarity thereto or a functional fragment thereof, for therapeutic use.

These peptides are encoded by an operon including any of the genes identified herein as phol-13, pho3-21, pho3-22, pho3-3, pho3-17, phol-5, pho3-23, pho3-50> phol-14, pho2-10, pho3-14, pho3-24 and pho3-?29, obtainable from Group B streptococcus, or a homologue or functional fragment thereof. Such peptides are suitable for therapeutic use, e.g. when isolated.

The term "functional fragments*1 is used herein to define a part of the gene or peptide which retains the activity of the whole gene or peptide. Por example, a functional fragment of the peptide may be used as an antigenic determinant, useful in a vaccine or in the production of antibodies.

A gene fragment may be used to encode the active peptide. Alternatively, the gene fragment may have utility in gene therapy, targetting the wild-type gene in vivo to exert jb. therapeutic pffect* Because of the extracellular or cell surface location, the peptide of the present invention may be suitable candidates for the production of therapeutically-effective vaccines against GBS. The term '• therapeutically-effactive" INTELLECTUAL PROPERTY OFFICE OF N.Z. - 2 MAR 2007 3 is intended to include the prophylactic effect of vaccines. For example, a vaccine may comprise a peptide according to the invention, or the means for its expression, for the treatment of infection. The vaccine may be administered to 5 females prior to or during pregnancy to protect mother and neonate against infection by GBS.

According to another aspect of the invention, the peptide or gene may be used for screening potential antimicrobial drugs or for the detection of virulence. 10 Also described is the use of any of the products identified herein, for the treatment or prevention- of a condition associated with infection by a Group B Streptococcal strain; for the treatment of focal infection; or for the treatment of a urinary tract infection.

Although the protein hais been described for iisfc in' the treatment of patients, veterinary uses of the prdducts of the invention are also considered to be within the scope of the present invention. In particular, the peptides or the vaccines may be used in the treatment of chronic mastitis, especially in cows.

The invention of New Zealand Specification Nos. 512297, 526879 and 535122 relate to a peptide encoded by an operon comprising the amino acid sequence identified *\ ; herein as SEQ ID NO: 23 (pho3-l), SEQ ID NO: 15 (pho2-2), and SEQ ID NO: 13 (pho2-15), respectively, obtainable from Group B Streptococcus, or a homologue having at least 70% sequence similarity thereto, or a functional fragment thereof, for 2o therapeutic use. o The present invention is described with reference to Group B Streptococcal strain M732. However, all the GBS strains and many other bacterial strains are likely to include related peptides or proteins haying amino acid 25 sequence homology with the peptide of M|732. Organisms likely to contain the peptides include/ but are not limited to, 5. pneumoniae, S. pyogenes, S. suis, S. milleri, Group C and Group G Streptococci and Enterococci. Vaccines to each of these may be developed in the same way as described 30 for GBS.

Preferably, the peptides that may be useful for the production of vaccines have greater than 40% sequence similarity with the peptides identified herein. More preferably, the peptides have greater than 60% sequence 35 similarity. Most preferably, the peptides have greater than 80% sequence similarity, e.g. 95% similarity. 4 Having characterised a gene according to the invention, it is possible to use the gene sequence to establish homologies in other microorganisms. In this way it is possible to determine whether other microorganisms 5 have similar outer surface products. Sequence homologies may be established by searching in existing databases, e.g. EMBL or Genbank.

Peptides or proteins according to the invention may be purified and isolated by methods known in the art. In 10 particular, having identified the gene sequence, it will be possible to use recombinant techniques to express the genes in a suitable- host.: Active fragments and homologues can be identified and may be useful in therapy; For example, the peptides or their active fragments may be used as antigenic .15. determinants in a vaccine, to elicit an immune response. They may also be used in the; preparation of antibodies, for passive immunisation, or diagnostic applications. Suitable antibodies include monoclonal antibodies, or fragments thereof, including single chain fv fragments. Methods for 20 the preparation of antibodies will be apparent to those skilled in the art.

The preparation of vaccines based on attenuated microorganisms is known to those skilled in the art. Vaccine compositions can be formulated with suitable 25 carriers or adjuvants, e.g. alum, as necessary or desired, and used in therapy, to provide effective immunisation against Group B Streptococci or other related microorganisms. The preparation of vaccine formulations will be apparent to the skilled person.

More generally, and as is well known to those skilled in the art, a suitable amount of an active component of the invention can be selected, for therapeutic use, as can suitable carriers or excipients, and routes of administration. These factors will be chosen or determined 35 according to known criteria such as the nature/severity of the condition to be treated, the type or health of the subject etc.

The products of the present invention were identified as follows: A partial gene library of GBS (strain M732) chromosomal DNA was prepared using the plasmid vectors pFW-5 phoAl, pFW-phoA2 and pFVI-phoA3 (Podbielski, A. et al. 1996. Gene 177:137-147). These plasmids possess a constitutive spectinomycin adenyltransferase antibiotic resistance marker, which confers a high level of spectinomycin resistance and is therefore easily selected. Furthermore, 10 these vectors contain a truncated (leaderless) Escherichia CQli phoA gene for alkaline phosphatase.. The three vectors differ only, with respect to the reading .frame in which the leaderless phoA gene exists/ as compared to anupstream in-frame Bamttl restriction enzyme site.' Because this 15 truncated E..- coliphoA gene lacks the appropriate leader sequence for export of this enzyme across the bacterial membrane, extracellular alkaline phosphatase activity is absent when these plasmids are propagated in an E. . coli phoA mutant (e.g. strain DH5a). The chromogenic alkaline 20 phosphatase substrate, XP (5-bromo-4-chloro-3-indolyl-phosphate), does not enter intact bacterial cells and therefore only exported or surface associated alkaline phosphatase activity can be detected. When exported or surface associated alkaline phosphatase activity is 25 present, the chromogenic XP substrate is cleaved to yield a blue pigment and the corresponding bacterial colonies can be identified by their blue colour.

Plasmid DNA was digested to completion with BamHI and dephosphorylated using shrimp alkaline phosphatase. GBS 30 genomic DNA was partially digested with Sau3AI, size fractionated on a sucrose gradient and fragments <lkb in size were ligated into the prepared pFW-phoA vectors. E. coli strain DH5a was chosen as the cloning host since it lacks a functional phoA gene. Recombinant plasmids were 35 selected on Luria agar containing 100 /ug/ml of spectinomycin and 40 nq/ml of the chromogenic XP substrate. E. coli transformants harbouring plasmids containing GBS 6 insert OHA that complements the export signal sequence of the leaderless phoA gene were identified by the blue colour of the colonies. Approximately 30000 different recombinant plasmids containing GBS. insert DNA were screened in this manner and 83 recombinant plasmids, which complemented the leaderless phoA, were chosen for further study.

From these experiments, several clones were selected each containing a plasmid containing a gene (or part thereof), which complemented the leaderless phoA.

Having identified the gene in each clone it is then possible to obtain the full-length gene sequence,, as follows.. • Using -the identified and sequenced gene -fragment, oligonucleotide primers were designed for genomic ~ DNA : sequencing. These primers were designed so as to sequence * in an "outward' direction.from the obtained sequence. Once read, the sequence obtained was checked to see if the 5* and 3 * termini of the gene had been reached. The presence of these features was identified by checking against homologous sequences, and for the 5' end the presence of an AUG start codon (or accepted equivalent) preceded by a Shine-Dalgamo consensus sequence, and for the 3' end, the presence of a translation termination (stop) codon.

Upon identification of the full-length gene, primers were designed for amplification of full-length product. Primers used included restriction enzyme recognition sites (Ncol at the 5*end and Eco0109I at the 3* end) to allow subsequent cloning of the product into the Lactococcal expression system used.

PCR was carried out using the primers, and the products cloned into a pCR 2.1 cloning vector (In Vitrogen). Following confirmation of the presence of the cloned fragment, the DNA was excised using the restriction enzymes Ncol and Eco0109I.

The vector into which this fragment was inserted was a modified version of pNZ8048 (Kuipers, O. P. et al. (1998) J. Biotech 64: 15-21). This vector, harbouring a 7 lactococcal origin of replication, a chloramphenicol resistance marker; an inducible nisin promoter and a multicloning site was altered by the replacement of the multicloning site with two 10X His tags, flanked on the 5-5 most end with an Ncol site, split in the middle with a multicloning site (including an EC00109I site), and a Stop (termination) codon at the .3*end of the His tags.

The gene of interest was inserted so that a 10X His tag was in the 3' position relative to the coding region. 10 Following transformation of the recombinant plasmid into L.lactis (strain NZ9000 -Kuipers, O.P. et al. (1998) supra), a 400 ml liquid culture was set up.and translation of the protein was. induced: by the addition of nisin to the culture. After a, 2 hour incubation, the cells were 15 harvested and lysed by bead beating. The resultant lysate was cleared by centrifugation, then passed over a metal affinity (Talon, Clonetech) column. The column was washed repeatedly before bound proteins were eluted with Imidazole.

To identify fractions containing the His-tagged recombinant protein, an aliquot from each fraction was analysed by SDS-PAGE, Western blotted and probed with anti-His antibodies.

The recombinant protein obtained was then used to 25 immunise New Zealand white rabbits, with pre-immune sera being harvested prior to immunisation. Following a boost, the rabbits were sacrificed and sera collected. This sera was used in Western blots, ELISA and animal protection models.

Using the sera obtained from the animal studies, immunosorption studies were carried out.

Group B Streptococcus was grown in 20ml Todd Hewitt broth (THB) for 8 hours, harvested and resuspended in 5ml PBS. 50/tl aliquots of this were used to coat wells in a 96 35 well plate (Nunc Immuno-Sorb). This was left at 4°C overnight to allow for adsorbance of the bacteria onto the plate. Plates were washed twice with PBS, then blocked 8 with 3%BSA in PBS for lhr at 37°C. Plates were again washed. Serial 10 fold dilutions of the sera were made in PBS and 50/41 of these dilutions were added to the wells of the plate, in duplicate. The plate was covered and 5 incubated for 1 hr at 37°C. The plate was washed, then 50/xl anti-rabbit alkaline phosphatase conjugated secondary antibody at a concentration of 1:5000 was added to each well. Following incubation at 37°C for an hour, the plate was washed again. 50/xl substrate (PNPP) was added to each 10 well, and the reaction allowed to proceed for 30min before the adsorbance was read at 405 nm.

Animal protection studies were also carried out to Y; - test the - effectiveness of protection' on the immunised' rabbits. Y< • * • ' -i ' GBS M732' was grown up in THB until mid-log phase was .; reached - approximately 5 hours; Cells were counted in a counting chamber, and bacteria were diluted to give a concentration of 2xl07 bacteria per ml in pre-immune or test sera. 50/il of this was injected via the 20 intraperitoneal route into 0-1 day old mice. The mice were observed for survival over 48 hours.

The following Examples illustrate the invention.

Example i A first clone. contained a gene sequence identified herein as SEQ ID NO. 1, with an amino acid sequence identified as SEQ ID NO. 2, and classified as phol-13.

A comparison of the amino acid sequence of phol-13 was performed.

Homologues to the GBS phol-13 gene product can be identified in Streptococcus pyogenes, S. pneumoniae, S. salivarius, Escherichia coli, Yersinia enterocolitica, Aquifex aeolicus, Helicobacter pylori and Haemophilus influenzae. The S. pyogenes and S. pneumoniae homologues 35 were identified from genome sequence data and no annotations were available as to the identity of the gene or gene products. In all other cases, the above homologues 9 can be identified as ATP-dependent Clp protease proteolytic subunits. The catalytic activity of Clp proteases results in the hydrolysis of proteins to small peptides in the presence of ATP and magnesium (Giffard, P.M. et al. 1993.

J. Gen. Microbiol. 139:913-920). Furthermore, the ClpP component of Clp proteases has been shown to be induced as part of the heat shock response (Kroh, H.E. and L.D. Simon. 1990. J. Bacterid. 172:6026-6034) and it is probable that this subunit or the complete proteolytic domain would 10 associated with the bacterial surface.

Immunisation studies, carried out as described above, - yielded the following results;- v .

.Treatment No animals No animals surviving • • •• - . at. time (hrs) • • 24 48 PBS 10 7 0.

Pre-immunised 37 13 0 Immunised 38 17 9 Example 2 A second clone was selected containing a plasmid designated phol-14. This plasmid contained a gene (or part thereof), which complemented the leaderless phoA. The nucleotide and deduced amino acid sequences are shown as SEQ ID NOS. 3 and 4, respectively.

A comparison of the amino acid sequence of phol-14 was performed.

Homologues to the GBS phol-14 gene product can be identified in Streptococcus pyogenes, Bnterococcus faecalis and Streptococcus pneumoniae. These homologues were 35 identified from genome sequence data and no annotations were available as to the identity of the gene or gene products. Additionally, two possible homologues were also identified from Shigella flexneri (SpaR) and Yersinia pseudotuberculosis (YsoT)-.- These latter two homologues are related proteins, believed to be anchored in the bacterial membrane (Bergman, T. et al. 1994. J. Bacterid. 176*2619-5 2626). In S. flexneri, the product of the spaR gene has been shown to be important for invasion of epithelial cells (Sasakawa, C. et al. 1993. J. Bacteriol. 175x2334-2346). Furthermore, the product of the spaR gene is also required for surface presentation of invasion plasmid antigens. The 10 analogous protein in Y. pseudotuberculosis is a component of the Yop. secretion system and is also important for virulence in this organism. pxampite 3 \ ' A - third clone was1 selected containing a plasmid: 15 designated phoi-5.; This plasmid contained a gene .(or part thereof), which complemented the leaderless phoA. The nucleotide and deduced amino acid sequences are shown as SEQ ID NOS. 5 and 6.

A comparison of the amino acid sequence of phol-5 was 20 performed.

Homologues to the GBS phol-5 gene product can only be identified in Streptococcus pyogenes and Staphylococcus carnosus (sceA). The S. pyogenes homologue was identified from genome sequence data and no annotations were available 25 as to the identity of the gene or gene products. Furthermore, little information is available on the function of the sceA gene product from S. carnosus. Hie see A gene product shows some sequence similarity to the aggregation promoting protein from Lactobacillus gasserl. 30 Based on analysis of the sceA gene product, this molecule contains a well-conserved signal sequence and is apparently secreted or associated with the bacterial cell surface, pyaffiple 4 A further clone was selected containing a plasmid 35 designated pho3-3. This plasmid contained a gene (or part thereof), which complemented the leaderless phoA. The 11 nucleotide and deduced amino acid sequences are shown as -SEQ ID NOS. 7 and 8. - A comparison of the amino acid sequence of pho3-3 was performed.

Homologues to the GBS pho3-3 gene product can be identified in Streptococcus nutans (rmic), (cpsM) S. pneumoniae and S. pyogenes. The s. pyogenes homologue was identified from genome sequence data and no annotations were available as to the identity of the gene or gene 10 product. In S. pneumoniae, the homologue can be identified as dTDP-4-keto-*6-deoxy glucoses-3,5-epimerase. in the .other two cases, the above homologues can be identified as- dTDP^ 4 -Jceto-L-rhamnose reductase (rmlC) - in S. mutants, - the , gene encoding this enzyme, rmlC, is part of the rati locus; -15 The rml locus consists, of .three : genes •which exhibit significant similarity to enzymes involved in the biosynthesis of dTDP-rhamnose, the immediate precursor of the rhamnose component in the S. mutans polysaccharide capsule (Tsukioka, Y. et al. 1997. J. Bacterid. 179:1126-20 1134). An analogous locus has also been identified in S. pneumoniae (Coffey, T.J. et al. 1998. Hoi. Hicobiol. 17:73-83). Almost all Streptococci characteristically possess rhamnose in their cell wall associated polysaccharides (Schleifer, K.H. and R. Kilper-BSlz. 1987. Syst. Appl. 25 Microbiol. 10:1-19), and it is highly probable that dTDP-4-keto-L-rhamnose reductase would be associated with the outer surface in Streptococci.

Example 5 A further clone was selected containing a plasmid 30 designated pho2-10. This plasmid contained a gene (or part thereof), which complemented the leaderless phoA.

The nucleotide sequence is shown as SEQ ID NO* 9. From this, upstream and downstream coding regions were identified, and the deduced amino acid sequences shown as 35 SEQ ID NOS. 10 and 11.

A comparison of the amino acid sequences of pho2-10 was performed. 12 Homologues to the GBS pho2-l0 gene product can be identified in Streptococcus pyogenes, Enterococcus faecalis, Debaryomyces occidentalis (hatl) and Escherichia coli (trkO). The S. pyogenes and E. faecalis homologues 5 were identified from genome sequence data and no annotations were available as to the identity of the gene or gene products. In the yeast D. occidentalis, the hakl gene is a homologue of the trkD gene from E. coli (Banuelos, M.A. et al. 1995. EMBO J. 14:3021-3027). The 10 trkD gene of E. coli is part of the kup potassium uptake system. The specific homolog identified here is the kup system -potassium uptake protein. The kup system is a constitutive potassium uptake.system in E * doll. The kup system ; potassium uptake . protein contains a highly 15 hydrophobic N-terminus that is predicted to span- the membrane at least 12 times. Kup is not homologous to other known membrane protein sequences. There is no indication of ATP binding, and it is proposed that the system is driven by a chemiosmotic gradient (Schleyer, M. & E.P. 20 Bakker, 1993. J. Bacterid. 175:6925-6931).

Example 6 A further clone was selected containing a plasmid designated pho2-15. This plasmid contained a gene (or part thereof), which complemented the leaderless phoA. The 25 nucleotide and deduced amino acid sequences of the gene are shown as SEQ ID NOS. 12 and 13.

A comparison of the amino acid sequence of pho2-15 was performed.

Homologues to the GBS pho2-i5 gene product can be 30 identified in Streptococcus pyogenes, Streptococcus pneumoniae, Enterococcus faecalis and Escherichia coli (gate and SgcC). The S. pyogenes, S. pneumoniae and E, faecalis homologues were identified from genome sequence data and no annotations were available as to the identity 35 of the gene or gene products. In E. coli, the gate and sgcC gene products can be identified as being the IIC component of phosphoenolypyruvate-dependent sugar 13 phosphotransferase systems (PTS), a major carbohydrate active-transport system. XrTPTS systems, the lie component is typically involved in binding of extracellular carbohydrates and forms a complex with the IID component to 5 constitute a membrane channel (Nobelmann, B. and J.W. Lengeler. 1995. Biochim. Biophys. Acta 1262:69-72). Exgpiple 7 A further clone was selected containing a plasmid designated pho2-2. This plasmid contained a gene (or part 10 thereof), which complemented the leaderless phoA. The nucleotide and deduced amino acid sequences of the gene are shown as SEQ ID NOS;- 14 and 15, respectively.- v. > A comparison of the amino acid sequence Of pho2-2 was ■ - performed. ■ Homologues to the GBS pho2-2 gene product can be identified in Enterococcusfaecal is,Escherichia coli (malK and afuC), Bacillus subtilis (glnO), Haemophilus influenzae (yebM and potA), Streptococcus pyogenes, Streptococcus pneumoniae and Salmonella typhimurium (maIK). The E. 20 faecalis, S, pyogenes and S. pneumoniae homologues were identified from genome sequence data and no annotations were available as to the identity of the gene or gene products. In all other cases, homologues represented ATP-binding transport proteins that are part of ABC type 25 transporters. Many of the components of ABC type transporters are membrane or cell surface associated, as these systems are involved in the transport of macromolecules from the extracellular environment to the intracellular compartment.

Example 8 A further clone was selected containing a plasmid designated pho3-14. This plasmid contained a gene (or part thereof), which complemented the leaderless phoA. The nucleotide and deduced amino acid sequences of the gene are 35 shown as SEQ ID NOS. 16 and 17.

A comparison of the amino acid sequence of pho3-14 was performed and no homologues could be identified in any of 14 the public databases. One homologue to the GBS pho3-l4 - -gene-product can be -identified -in Streptococcus -pyogenes, but this homologue was identified from genome sequence data and no annotations were available as to the identity of the 5 gene or gene product. Using this S. pyogenes homologue to search the public databases yielded no further information. Since the pho3-l4 product complemented the leaderless phoA gene, it can be concluded that this protein (or part thereof) would most probably be located extracellularly. 10 Example 9 A further clone was selected containing a<plasmid ■designated pho3-17. This;plasmid contained a gene (or part-thereof), which complemented the leaderless phoA. The nucleotide- and deduced amino acid sequences of the gene are 15 shown as SEQ ID NOS. 18 and 19. .

A comparison of the amino acid sequence of pho3-l7:was performed.

Homologues to the GBS Pho3-17 gene product can be identified in Streptococcus nutans and Lactococcus lactis, 20 with similarity being shown to N-acetyl muramidase. Similarity is also seen with an unidentified gene, yubE from Bacillus subtills.

N-acetylmuramidase is an autolysin that is involved in cell division. Using this limited information along with 25 the fact that pho3-17 complemented the leaderless phoA gene, it can be concluded that the pho3-17 product would most probably be located extracellularly.

Example 10 A further clone was selected containing a plasmid 30 designated pho3-18. This plasmid contained a gene (or part thereof), which complemented the leaderless phoA. The nucleotide and deduced amino acid sequences Of the gene are shown as SEQ ID NOS. 20 and 21.

A comparison of the amino acid sequence of pho3-18 was 35 performed.

Homologues to the GBS pho3-18 gene product can be identified in Streptococcus pyogenes and Streptococcus pneumoniae. These homologues were identified from genome sequence data and no annotations were available as to the identity of the gene or gene products. Using these S. pyogenes and S. pneumoniae homologues to search the public 5 databases showed some similarity to outer surface and membrane spanning proteins. Since the ORF3-18 product complemented the leaderless phoA gene, it can be concluded that this protein (or part thereof) would most probably be located extracellularly.

Example U A further clone was selected containing a plasmid . designated pho3-i.- This.plasmid contained a gene (or part thereof), which complemented the leaderless phoA. The nucleotide and deduced amino acid sequences of' the gene are 15 shown as SEQ ID NOS.< 22 and 23.

A comparison of the amino acid sequence of pho3-l was. performed.

Homologues to the GBS pho3-l gene product can be identified in Streptococcus pyogenes, Streptococcus 20 pneumoniae, Bacillus subtilis (yutD) and Enterococcus faecalis. The S. pyogenes, S. pneumoniae and E. faecalis homologues were identified from genome sequence data and no annotations were available as to the identity of the gene or gene products. In B. subtilis, the function of the yutD 25 gene product is unknown. It can be noted however, that the yutD gene is located on the £. subtilis chromosome in a region containing genes involved in cell wall synthesis. The fact that this DNA sequence complemented the leaderless phoA gene suggests that this gene product is 30 extracellularly located.

Example 12 A further clone was selected containing a plasmid designated pho3-21. This plasmid contained a gene (or part thereof), which complemented the leaderless phoA. The 35 nucleotide and deduced amino acid sequences of the gene are shown as SEQ ID NOS. 24 and 25. 16 A comparison of the amino acid sequence of pho3-21 was —performed.

Homologues to the GBS pho3-21 gene product can be identified in Streptococcus pyogenes, Streptococcus 5 pneumoniae, Lactobacillus fermentum (bspA) and Lactobacillus reuteri (cnb). The S. pyogenes and S. pneumoniae homologues were identified from genome sequence data and no annotations were available as to the identity of the gene or gene products. In L. fermentum, the bspA 10 gene product has been identified as being a basic cell surface-located protein that has some sequence similarity, to. family III of the bacterial solute--binding proteins (Turner, U.S. et al. 1997,* J. Bacteriol> 179;:J?310--3316).: In TL. reuteri, the cnb gene product has been identified as -15 a collagen binding protein that has some sequence -similarity to the solute-binding component. of bacterial ABC transporters (Roos, S. et al. 1996. FEMS Microbiol. Lett. 144:33-38).

Example 13 A further clone was selected containing a plasmid designated pho3-22. This plasmid contained a gene (or part thereof), which complemented the leaderless phoA. The nucleotide and deduced amino acid sequences of the gene are shown as SEQ ID NOS. 26 and 27.

A comparison of the amino acid sequence of pho3-22 was performed.

Homologues to the GBS pho3-22 gene product can be identified in Enterococcus faecalis, streptococcus equisimilis (lppc), Pseudomonas fluorescens (oprl) and 30 Streptococcus thermophilus (orfl42). The E. faecalis homolog was identified from genome sequence data and no annotations were available as to the identity of the gene or gene products, in S. equisimilis, the lppC gene product has been identified as being a lipoprotein that is 35 homologous to the E(P4) outer membrane protein from Haemophilus influenzae (Gase, K. et al. 1997. Med. Microbiol. Immunol. 186:63-73). Likewise, the J>. 17 fluorescens oprl gene encodes a major outer membrane lipoprotein (Cornelia, P. et al. 1989. Mol. Microbiol. 3:421-428). In S. thermophilus, the orfl42 product has been putatively identified as a cell surface exposed 5 lipoprotein that may act as a receptor for the bacteriophages TP-J34 and Sfi21 (Neve, H. et al. 1998. Virology 241:61-72). The ORF3-22 product showed good similarity to the above homologues, particularly at the N-terminus. This is most likely the region required for 10 complementation of the leaderless phoA gene, and therefore serves as a leader, sequence.

Example H A further clone was selected containing "a plesinid designated pho3-23. This plasmid contained a gene (or part" 15 thereof), which complemented the leaderless phoA. The nucleotide and deduced amino acid sequences of the genes are shown as SEQ ID NOS. 28 and 29.

A comparison of the amino acid sequence of pho3-23 was performed.

Homologues to the GBS pho3-23 gene product can be identified in Streptococcus pyogenes, Streptococcus pneumoniae, Enterococcus faecalis and Streptococcus nutans (perM). The S. pyogenes, S. pneumoniae and E. faecalis homologues were identified from genome sequence data and no 25 annotations were available as to the identity of the gene or gene products. In S. nutans, the perM gene product has been presumptively identified as a permease, but no other information is available as to the function of this protein. considering that the pho3-23 coding region 30 complements the leaderless phoA gene, it can be concluded that the pho3-17 gene product would most probably be located extracellularly.

Example 15 A further clone was selected containing a plasmid 35 designated pho3-24. This plasmid contained a gene (or part thereof), which complemented the leaderless phoA. The 18 nucleotide and deduced amino acid sequences of the qene are shown as SEQ ID NOS. 30 and 31.

A comparison of the amino acid sequence of pho3-24 was performed.

Homologues to the GBS pho3-24 gene product can be identified in Streptococcus nutans (dltB), streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus faecalis, Lactobacillus casei (dltB) and Bacillus subtilis (dltB). The S. pneumoniae, S. pyogenes and E. fdecalis homologues 10 were identified from genome sequence data and no annotations were available as to the identity of the gene or gene products. In S. mutans, L. casei and B. subtilis, the dltB gene product has been identified as beirig a bagic membrane. protein that is involved in the transport of 15 . activated ^Dr-alanine through the cell membrane. ■ The1' dltB gene product is involved in the biosynthesis of D-aianyl-lipoteichoic acid (Heaton, M.P. and F.C. Neuhaus. 1992. J. Bacteriol. 174:4707-4717). In L. casei and B. subtilis, the dltB gene product is believed to contain at least 9 20 membrane spanning domains, indicating that the protein or portions thereof are exposed to the outside of the cell. Example 16 A further clone was selected containing a plasmid designated pho3-29. This plasmid contained a gene (or part 25 thereof), which complemented the leaderless phoA. The nucleotide and deduced amino acid sequences of the gene are shown as SEQ ID NOS. 32 and 33.

A comparison of the amino acid sequence of pho3-29 was performed.

Homologues to the GBS pho3-29 gene product can be identified in Borrelia burgdorferi (p23 or ospC), Bacillus brevis (owp) and Pseudomonas aeruginosa (oprl). Although these homologues are not related to each other, they all represent major outer surface proteins. In B. burgdorferi, 35 the ospC gene product has been identified as being a 23-kDa protein that is the immunodominant antigen on the surface of this bacterium (Padula, S.J. et al. 1993. Infect. Iramun. 19 61:5097-5105). The owp gene product from B. brevis is one of..two. major cell wall proteins involved in the surface layer lattice (Tsuboi, A. 1988. J. Bacterid. 170:935-945). Finally, the oprl gene from P. aeruginosa encodes a major 5 outer membrane lipoprotein precursor (Saint-Onge, A. et al. 1992. J. Gen. Microbiol. 138:733-741).

Example 17 A further clone was selected containing a plasmid designated pho3-50. This plasmid contained a gerie (or part 10 thereof), which complemented the leaderless phoA. The nucleotide and deduced amino acid sequences of the gene are shown as SEQ ID NOS. 34 aftd 35.

A comparison of the amino acid sequence of;pho3^50 was' ■performed.? ' .15 Homologues to the GBS pho3-50 gene product can be identified in a variety of Streptococci (penA, pbp2B, pbpB2), Borrelia burgdorferi (pbp2) , Enterococcus faecalis (pbpC), Staphylococcus aureus (pbpA), Mycobacterium leprae (pbpB) and Helicobacter pylori (pbp2). In all cases, the 20 above homologues can be identified as penicillin binding proteins (PBPs). Genes encoding penicillin binding proteins are often located in a cluster of genes associated with cell wall synthesis (pucci, M.J. et al. 1997. J, Bacteriol. 179:5632-5635). Furthermore, PBPs are typically 25 integrated into the cell wall of a bacterium with some or all of the protein being exposed on the outer bacterial stir face.

Claims (20)

WHAT WE CLAIM IS: 20

1. A peptide comprising a sequence of SEQ ID NO: 21, or a homologue having at least 70% sequence similarity thereto or a functional fragment thereof, for therapeutic use.

2. A peptide as claimed in claim 1, wherein said homologue has at least 80% sequence similarity thereto.

3. A peptide as claimed in claim 1 or 2, wherein said homologue has at least 95% sequence similarity thereto.

4. A peptide comprising a sequence of SEQ ID NO: 21 for therapeutic use.

5. A polynucleotide encoding a peptide according to any one of claims 1 to 4 for therapeutic use.

6. A host cell transformed to express a peptide according to any one of claims 1 to 4 with the proviso that said host cell is not present in a human.

7. A vaccine comprising a peptide according to any one of claims 1 to 4.

8. Use of a peptide, polynucleotide or host cell according to any one of claims 1 to 6, for screening potential drugs or for the detection of virulence.

9. Use of a peptide, polynucleotide or host cell according to any one of claims 1 to 6, for the manufacture of a medicament for use in the treatment or prevention of a condition associated with bacterial infection.

10. Use according to claim 9, wherein the infection is a Group B streptococcal infection.

11. Use according to claim 9 or claim 10, wherein the infection is a focal infection.

12. Use according to claim 9 or claim 10, wherein the infection is a urinary tract infection.

13. An isolated antibody raised against a peptide according to any one of claims 1-4.

14. A peptide as claimed in claim 1 or 4 substantially as herein described or exemplified.

15. A polynucleotide as claimed in claim 5 substantially as herein described or exemplified.

16. A host cell as claimed in claim 6 substantially as herein described or exemplified.

17. A vaccine as claimed in claim 7 substantially as herein described or exemplified.

18. A use as claimed in any one of claims 8 to 12 substantially as herein described or exemplified.

19. An isolated antibody as claimed in claim 13 substantially as herein described or exemplified. INTELLECTUAL PROPERTY OFFICE OF N.2T - 8 MAY 2008 DOC SEQUENCE LISTING <110> Microscience Limited <120> GENES AND PROTEINS, AND THEIR USE <130> REP05973WO <140> <141> <X60> 35 <170> Patentln Ver. 2.1 . <210>,1 ; <211> 587 k <212> DNA <213> group B streptococcus . <220> <221> CDS <222> (1)..(582) <400> 1 atg ate cca gta gta ate gaa caa aca agt cgt ggt gaa cgt tct tat 48 Met He Pro Val Val lie Glu Gin Thr Ser Arg Gly Glu Arg Ser Tyr 1 5 10 15 gat att tac tea cgt ctt tta aaa gat cgt att att atg ttg aca ggc 96 Asp lie Tyr Ser Arg Leu Leu Lys Asp Arg lie lie Met Leu Thr Gly 20 25 30 caa gtt gag gat aat atg gcc aat agt ate att gca cag tta ttg ttt 144 Gin Val Glu Asp Asn Met Ala Asn Ser lie lie Ala Gin Leu Leu Phe 35 40 45 ctc gat gca caa gat aat aca aag gat att tac ctt tat gtc aat aca 192 Leu Asp Ala Gin Asp Asn Thr Lys Asp lie Tyr Leu Tyr Val Asn Thr 50 55 60 cca ggt ggt tea gta teg get gga ctt get att gtg gac acc atg aac 240 Pro Gly Gly Ser Val Ser Ala Gly Leu Ala lie Val Asp Thr Met Asn 65 70 75 80 ttc att aaa teg gac gta cag acg att gtt atg ggg atg get get teg 288 Phe lie Lys Ser Asp Val Gin Thr lie Val Met Gly Met Ala Ala Ser 85 90 95 1 atg gga acc Met Gly Thr att att get tea agt ggt get aaa gga aaa cgt ttt atg 336 lie He Ala Ser Ser Gly Ala Lys Gly Lys Arg Phe Met 100 105 110 tta ecg aat gca gaa tat atg ate cac caa cca atg ggc gga aca ggc 384 Leu Pro Asn Ala Glu Tyr Met lie His Gin Pro Met Gly Gly Thr Gly 115 120 125 gga ggt aca cag caa tct gat atg get ate get get gag cat ctt tta 432 Gly Gly Thr Gin Gin Ser Asp Met Ala lie Ala Ala Glu His Leu Leu 130 135 140 aaa acg cgt cat act tta gaa aaa ate tta get gat aat tct ggt caa 480 Lys Thr Arg His Thr Leu Glu Lys lie Leu Ala Asp Asn Ser Gly Gin 145 150 155 ; 160 tct att gaa aaa gte cat gat gat gca gag cgt gat cgt .tgg. atg agt 52.8 Ser lie Glu Lys Val His Asp Asp Ala. Glu Arg Asp. Arg Trp Met Ser 165 1.70 175 get caa gaa aca ctt gat tat ggc ttt att gat gaa ate atg get aat 576 Ala Gin Glu Thr Leu Asp Tyr Gly Phe lie Asp Glu lie Met Ala Asn 180 185 190 aat gaa taagg 587 Asn Glu <210> 2 <211> 194 <212> PRT <213> group B streptococcus <400> 2 Met lie Pro Val Val lie Glu Gin Thr Ser Arg Gly Glu Arg Ser Tyr 1 5 10 15 Asp lie Tyr Ser Arg Leu Leu Lys Asp Arg lie He Met Leu Thr Gly 20 25 30 Gin Val Glu Asp Asn Met Ala Asn Ser lie He Ala Gin Leu Leu Phe 35 40 45 Leu Asp Ala Gin Asp Asn Thr Lys Asp lie Tyr Leu Tyr Val Asn Thr 50 55 60 Pro Gly Gly Ser Val Ser Ala Gly Leu Ala lie Val Asp Thr Met Asn 2 65 70 75 80 Phe lie Lys Ser Asp Val Gin The lie Val Met Gly Met Ala Ala Ser _ 85 - 90— —, 95 Met Gly Thr lie He Ala Ser Ser Gly Ala Lys Gly Lys Arg Phe Met 100 105 110 Leu Pro Asn Ala Glu Tyr Met lie His Gin Pro Met Gly Gly Thr Gly 115 120 125 Gly Gly Thr Gin Gin Ser Asp Met Ala lie Ala Ala Glu His Leu Leu 130 135 140 Lys Thr Arg His Thr Leu Glu Lys lie Leu Ala Asp Asn Ser Gly Gin 145 150 155 160 Ser lie. Glu Lys Val His Asp Asp Ala Glu Arg Asp Atg Trp Het Ser 165 •• 170 175 Ala Gin Glu Thr Leu Asp Tyr Gly Phe He Asp Glu He Met Ala Asn 180 185 190 Asn Glu <210> 3 <211> 218 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1)..(216) <400> 3 ate aga gca tat tct ggt cct ctt teg gtt ttc ctg cca egt ttt aaa 48 He Arg Ala Tyr Ser Gly Pro Leu Ser Val Phe Leu Pro Arg Phe Lys 1 5 10 15 get tgt gat ata ata gtc aat gtg agg agg act ate atg tta ttt aag 96 Ala Cys Asp He lie Val Asn Val Arg Arg Thr lie Met L.eu Phe Lys 20 25 30 gaa aaa att cct gga eta ata tta tgc ttt att att get ata cca tct 144 Glu Lys lie Pro Gly Leu lie Leu Cys Phe lie He Ala lie Pro Ser 3 35 40 45 tgg ttg ctt ggg ctt tat ctc cct tta ata gga gca cca gtc ttt get 192 Trp Leu Leu Gly Leu Tyr Leu Pro Leu lie Gly Ala. Pro Val Phe Ala 50 55 60 ate tt.g att gga ata att gtt gga tc 216 lie Leu lie Gly lie lie Val Gly 65 70 <210> 4 <211> 72 <212> PRT <213> group B streptococcus <400> 4 ..lie Arg . Ala Tyr Ser Gly Pro Leu Ser Val Phe Leu -Pro Arg Phe Lys 1 5 10 15 Ala Cys Asp lie lie Val Asn Val Arg Arg Thr lie Met Leu Phe Lys 20 25 30 Glu Lys He Pro Gly Leu lie Leu Cys Phe lie lie Ala lie Pro Ser 35 40 45 Trp Leu Leu Gly Leu Tyr Leu Pro Leu He Gly Ala Pro Val Phe Ala 50 55 60 He Leu He Gly He lie Val Gly 65 70 <210> 5 <211> 705 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1)..(705) <400> 5 atg aat aaa aga aga aaa tta tea aaa ttg aat gta aaa aar caa cat 48 Met Asn Lys Arg Arg Lys Leu Ser Lys Leu Asn Val Lys Lys Gin His 1 5 10 15 tta get tat gga get ate act tta gta gcc ctt ttt tea tgt att ttg 96 Leu Ala Tyr Gly Ala lie Thr Leu Val Ala Leu Phe Ser Cys lie Leu 20 25 30 get gta acg gtc ate ttt aaa agt tea caa gtt act act gaa tct ttg 144 Ala Val The Val Xle Phe Lys Ser Ser Gin Val The The Glu see Leu 35 40 45 tea aaa gca gat aaa gtt cgc gta gcc aaa aaa tea aaa atg act aag 192 Ser Lys Ala Asp Lys Val Arg Val Ala Lys Lys Ser Lys Met Thr Lys 50 55 60 gcg aca tct aaa tea aaa gta gaa gat gta aaa cag get cca aaa cct 240 Ala Thr Ser Lys Ser Lys Val Glu Asp Val Lys Gin Ala pro Lys Pro 65 70 75 80 tct cag gca tct aat gaa gcc cca aaa tea agt tct caa tct aca gaa 288; . Ser Gin Ala Ser Asn Glu. Ala . Pro Lys Ser Ser Ser Gin ser Thr. Glu . . 85 90 95 get aat tct cag caa caa gtt act gcg agt gaa gag acg get gta gaa - 336 Ala Asn Ser Gin Gin Gin Val Thr Ala Ser Glu Glu Thr Ala Val Glu 100 105 110 caa gca gtt gta aca gaa ata ccc ctg eta cca gtc agg cac aac aac 384 Gin Ala Val Val Thr Glu lie Pro Leu Leu Pro Val Arg His Asn Asn 115 120 125 ctt tat get gtt act gag aca cct tac aac cct get caa cca cca gac 432 Leu Tyr Ala Val Thr Glu Thr Pro Tyr Asn Pro Ma Gin Pro Pro Asp 130 135 140 caa gtg gcc agg tat gag caa tgg aaa tac tgc cag gcg gtc gga tct 480 Gin Val Ala Arg Tyr Glu Gin Trp Lys Tyr Cys Gin Ala val Gly Ser 145 150 155 160 get get gca gca caa atg get get gca aca gga gtc cct cag tct act 528 Ala Ala Ala Ala Gin Het Ala Ala Ala The Gly Val Pro Gin Ser The 165 170 175 tgg gaa cat att att gcc cgt gaa tea aat ggt aat cct aat gtt get 576 Trp Glu His lie He Ala Arg Glu see Asn Gly Asn Pro Asn Val Ala 180 185 190 aat gcc tea gga get tea gga ett ttc caa acg atg cca ggt tgg ggt 624 Asn Ala Ser Gly Ala Ser Gly Leu Phe Gin The Met Peo Gly Tep Gly 195 200 205 5 tea aca get aca gtt cag gat caa gta att cag eta tta aag ctt att 672 Sex Thr Ala Thr Val Gin Asp Gin Val lie Gin Leu Leu Lys Leu lie 210 215 220 cgt get caa ggg tta tea get ggg tac cag tga 705 Arg Ala Gin Gly Leu ser Ala Gly Tyr Gin 225 230 235 <210>.6 <211> 234 <212> PRT <213> group B streptococcus <400> 6 Met Asn Lys Arg Arg lys Leu Ser Lys Leu Asn Val Lys Lys Gin His 1 5 10- 15 Leu Ala Tyr Gly Ala He Thr Leu Val Ala Leu Phe Ser.Cys -lie' Leu 20 25 30 - Ala Val Thr Val lie Phe Lys Ser Ser Gin Val Thr Thr Glu Ser Leu ' 35 40 45 ser Lys Ala Asp Lys Val Arg Val Ala Lys Lys Ser Lys Met Thr Lys 50 55 60 Ala Thr Ser Lys Ser Lys val Glu Asp Val Lys Gin Ala Pro Lys Pro 65 70 75 80 Ser Gin Ala Ser Asn Glu Ala Pro Lys Ser Ser Ser Gin Ser Thr Glu 85 90 95 Ala Asn Ser Gin Gin Gin Val Thr Ala ser Glu Glu Thr Ala Val Glu 100 105 110 Gin Ala Val Val Thr Glu lie Pro Leu Leu Pro Val Arg His Asn Asn 115 120 125 Leu Tyr Ala Val Thr Glu Thr Pro Tyr Asn Pro Ala Gin Pro Pro Asp 130 135 140 Gin Val Ala Arg Tyr Glu Gin Trp Lys Tyr Cys Gin Ala val Gly Ser 145 150 155 160 Ala Ala Ala Ala Gin Met Ala Ala Ala Thr Gly Val Pro Gin Ser Thr 165 170 175 6 Trp Glu His lie lie Ala Arg Glu Ser Asn Gly Asn Pro Asn Val Ala 180 185 190 Asn Ala Ser Gly Ala Ser Gly Leu Phe Gin Thr Met Pro Gly Trp Gly 195 200 205 Ser Thr Ala Thr val Gin Asp Gin Val Zle Gin Leu Leu Lys Leu lie 210 215 220 Arg Ala Gin Gly Leu Ser Ala Gly Tyr Gin 225 230 <210> 7 <211> 594 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1) ..(594) <400> 7 atg act gaa cca ttt ttt gat aaa gaa tta act tgt cgc cca att gaa 48 Met Thr . Glu Pro Phe Phe Asp Lys Glu Leu Thr Cys Arg Pro lie Glu 15 10 15 gcc att cct gaa ttg ttg gaa ttc gat att acc gtt cgt gga gac aac 96 Ala Zle Pro Glu Leu Leu Glu Phe Asp lie Thr Val Arg Gly Asp Asn 20 25 30 cgt gga tgg ttc aaa gag aac ttt caa aaa gaa aaa atg ata ccg ctt 144 Arg Gly Trp Phe Lys Glu Asn Phe Gin Lys Glu Lys Met lie Pro Leu 35 40 45 ggt ttc cca gaa age ttc ttt gag gca gac aaa eta caa aat aat att 192 Gly Phe Pro Glu Ser Phe Phe Glu Ala Asp Lys Leu Gin Asn Asn lie 50 55 60 teg ttt aca aaa aaa aat act ttg cga ggt etc cat gca gag cct tgg 240 Ser Phe Thr Lys Lys Asn Thr Leu Arg Gly Leu His Ala Glu Fro Trp 65 70 75 80 gat aaa tat gtt teg ate get gat gaa gga cgt gtg ate ggt act tgg 288 Asp Lys Tyr Val Ser lie Ala Asp Glu Gly Arg Val lie Gly Thr Trp 85 90 95 7 gtt gac ctc cgt gaa ggt gac agt ttt ggt aac gtt tac caa acg att 336 Val Asp Leu Acg Glu Gly Asp Ser Phe Gly Asn Val Tyr Gin Thr lie 100 105 110 ate gat gee tea aaa ggt att ttt gtt cca cgc ggc gtt get aat ggt 384 lie Asp Ala Ser Lys Gly Zle Phe Val Pro Arg Gly Val Ala Asn Gly 115 120 125 ttc caa gtt ctt tea gat aaa gca get tat act tat ctc gtt aac gat 432 Phe Gin Val Leu Ser Asp Lys Ala Ala Tyr Thr Tyr Leu Val Asn Asp 130 135 140 tat tgg gca ctt gaa ctc aaa cca aaa tat get ttc gtt aac tat gca 480 Tyr Trp Ala Leu Glu Leu Lys Pro Lys Tyr Ala Phe Val Asn Tyr Ala 145 150 155 160 gat cca aat eta ggc att cag tgg gaa aat ctw gaa gaa gca gaa .gtc. . 528 Asp Pro Asn Leu Gly lie Gin Trp Glu Asn Xaa Glu Glu Ala Glu Val 165 170 175 ••••: tea gaa gca gat aag aat cac cca ctt ctc aaa gat gta aaa oct ttg 576 Ser Glu Ala Asp Lys Asn Mis Pro Leu Leu Lys Asp Val Lys Pro Leu 180 185 190 aag aag gaa gat ttg taa 594 Lys Lys Glu Asp Leu 195 <210> 8 <211> 197 <212> PRT <213> group B streptococcus <400> 8 Met Thr Glu Pro Phe Phe Asp Lys Glu Leu Thr Cys Arg Pro Zle Glu 15 10 15 Ala Zle Pro Glu Leu Leu Glu Phe Asp Zle Thr Val Arg Gly Asp Asn 20 25 30 Arg Gly Trp Phe Lys Glu Asn Phe Gin Lys Glu Lys Met Zle Pro Leu 35 40 45 Gly Phe Pro Glu Ser Phe Phe Glu Ala Asp Lys Leu Gin Asn Asn Zle 50 55 60 Ser Phe Thr Lys Lys Asn Thr Leu Arg Gly Leu His Ala Glu Pro Trp 8 £5 70 75 80 Asp Lys Tyr Val Ser lie Ala Asp Glu Gly Arg Val lie Gly Thr Trp 85 90 95 Val Asp Leu Arg Glu Gly Asp Ser Phe Gly Asn Val Tyr Gin Thr lie 100 105 110 lie Asp Ala Ser Lys Gly lie phe Val Pro Arg Gly Val Ala Asn Gly 115 120 125 Phe Gin Val Leu Ser Asp Lys Ala Ala Tyr Thr Tyr Leu Vai Asn Adp 130 135 140 Tyr Trp Ala Leu Glu Leu Lys Pro Lys Tyr Ala Phe Val? Asn Tyr Ala 145 150 155 160 Asp. Pro,Asn Leu Gly He Gin Trp Glu Asn Xaa Glu Glu Ala Glu Val 165 170 175 . Ser Glu Ala Asp Lys Asn His Pro Leu Leu Lys Asp Val Lys Pro Leu 180 185 190 Lys Lys Glu Asp Leu 195 <210> 9 <211> 1217 <212> DNA <213> group B streptococcus <220> <221> CDS <222> <1>..(570) <220> <221> CDS <222> (679)..(945) <400> 9 tat tat tta ate gga ggg ttg gca gaa atg caa cat gtc aat cat tct 48 Tyr Tyr Leu lie Gly Gly Leu Ala Glu Met Gin His Val Asn His Ser 15 10 15 tct ttt gat aaa gca tea aaa gca gga ttt att att get tta ggc att 96 Ser Phe Asp Lys Ala Ser Lys Ala Gly Phe He He Ala Leu Gly lie 9 20 25 30 gtt tat gga gat att ggt aca ago cca ctc tat acg atg caa tea ttg 144 Val Tyr Gly Asp lie Gly Thr Ser Pro leu Tyr Thr Met Gin Ser Leu 35 40 45 gtt gaa aac caa ggt ggt att tct agt gtc aca gaa teg ttt ate tta 192 Val Glu Asn Gin Gly Gly lie Ser Ser Val Thr Glu Ser Phe He Leu 50 55 60 ggt tct ata tct tta ate ata tgg acc ttg aca ctt att aca act ate 240 Gly Ser Zle Ser Leu Zle Zle Trp Thr Leu Thr Leu Zle Thr Thr Zle 65 70 75 80 aag tat gtg ctt gta get tta aag gcg gat aat cac cac gaa ggt ggt. 288 Lys Tyr Val Leu Val Ala Leu Lys Ala Asp Asn His His GluGly Gly 85 90 95 att ttt tct tta tat acc ctt gtt aga aaa atg aca cct tgg tta att 336 Zle Phe Ser Leu Tyr Thr Leu Val Arg Lys Met Thr Pro Trp Leu Zle 100 105 110 gtt ccg get gtt att gga ggt gca acc ttg ttg tea gat gga get ttg 384 Val Pro Ala Val Zle Gly Gly Ala Thr Leu Leu Ser Asp Gly Ala Leu 115 120 125 acg cca get gta acc gta ctt cag ccg tta agg att aaa gta gtt cct 432 Thr Pro Ala Val Thr Val Leu Gin Pro Leu Arg Zle Lys Val Val Pro 130 135 140 agt ttg cag cat att tcc aga ate aga gta tgt tat ttt gcg acc ttg 480 Ser Leu Gin His Zle Ser Arg Zle Arg Val Cys Tyr Phe Ala Thr Leu 145 150 155 160 tta ttt act gtt act ttt gcc ate caa ggt ttg gaa egg gtg tta ttg 528 Leu Phe Thr Val Thr Phe Ala Zle Gin Gly Leu Glu Arg Val Leu Leu 165 170 175 gaa tta ttg gcc att atg tta tat ggt ttg cct ttt ggt tta 570 Glu Leu Leu Ala Zle Met Leu Tyr Gly Leu Pro Phe Gly Leu 180 185 190 ncggtctcct tatagttttg cccatccaga agttttcaag cattaatcca tactacggtt 630 tgaaattgtt atttagtcca gagaatcata aaggtatttt tattttag gat eta ttt 687 Asp Leu Phe tcc tgg cga caa acg gga gca gaa gca eta tac tct gac tta ggt cat 735 10 Ser Trp Arg Gin Thr Gly Ala Glu Ala Leu Tyr Ser Asp Leu Gly His 195 200 205 gtt ggg cgt gga aat ata cat gtt tea tgg ccg ttc gtt aag gtt gcc 783 Val Gly Arg Gly Ash lie His Val Ser Trp Pro Phe Val Lys Val Ala 210 215 220 225 att ata ctt tct tat tgt ggg caa ggg gca tgg att tta get aat aag 831 lie lie Leu Ser Tyr Cys Gly Gin Gly Ala Trp lie Leu Ala Asn Lys 230 235 240 aac gca gga aat gaa ttg aat ccc ttt ttt get agt att cct teg caa 879 Asn Ala Gly Asn Glu Leu Asn Pro Phe Phe Ala Ser lie Pro Ser Gin 245 250 255 ttt aca atg cat gtc gtt att tta get act ttg gca get ate ate get 923 Phe Thr Met His Val Val He Leu Ala Thr Leu Ala Ala lie He Ala 260 265 270 tea cag gca ctg att tct ggatcaattt acCttaagtt: ctgagctatg 975 Ser Gin Ala Leu He Ser 275 cgactaaaaa tattcccaca atttegttea acttatcctg ttgacaatat tgggtcaaac 1035 ' ctacatacct ggtattaatt ggttcttatt tgccattaca acctctattg gtttgctttt 1095 taagacttca gcgcacatgg aagcagcata tggattagcg ataacaatta egatgetaat 1155 gacaactatt ttactgtctt tctttttaat tcaaaaagga gtaaagagag gttttagcta 1215 tt 1217 <210> 10 <211> 190 <212> PRT <213> group B streptococcus <400> 10 Tyr Tyr Leu lie Gly Gly Leu Ala Glu Met Gin His Val Asn His Ser 1 5 10 15 Ser Phe Asp Lys Ala Ser Lys Ala Gly Phe Xle lie Ala Leu Gly He 20 25 30 Val Tyr Gly Asp lie Gly Thr Ser Pro Leu Tyr Thr Met Gin Ser Leu 35 40 45 11 Val Glu Asn Gin Gly Gly lie Ser Ser Val Thr Glu Ser Phe 50 55 60 lie Leu Gly Ser lie ser Leu Zle lie Trp Thr Leu Thr Leu He Thr Thr lie 65 70 75 80 Lys Tyr Val Leu Val Ala Leu Lys Ala Asp Asn His His Glu Gly Gly 65 90 95 He Phe Ser Leu Tyr Thr Leu Val Arg Lys Met Thr Pro Trp Leu He 100 105 110 Val Pro Ala Val He Gly Gly Ala Thr Leu Leu Ser Asp Gly Ala Leu 115 120 125 Thr Pro Ala Val Thr Val Leu Gin Pro Leu Arg lie Lys Val Val Pro • 130 135 140 Ser Leu Gin His lie Ser Arg lie Arg Val cys Tyr Phe Ala Thr-lieu : 145 150 155 160 Leu Phe Thr Val Thr Phe Ala lie Gin Gly Leu Glu Arg Val Leu Leu 165 170 175 Glu Leu Leu Ala Zle Met Leu Tyr Gly Leu Pro Phe Gly Leu 180 185 190 <210> 11 <211> 89 <212> PRT <213> group B streptococcus <400> 11 Asp Leu Phe Ser Trp Arg Gin Thr Gly Ala Glu Ala Leu Tyr Ser Asp 1 5 10 15 Leu Gly His Val Gly Arg Gly Asn Zle His Val Ser Trp Pro Phe Val 20 25 30 Lys Val Ala lie Zle Leu Ser Tyr Cys Gly Gin Gly Ala Trp lie Leu 35 40 45 Ala Asn Lys Asn Ala Gly Asn Glu Leu Asn Pro Phe Phe Ala Ser Zle 50 55 60 Pro Ser Gin Phe Thr Met His Val Val Zle Leu Ala Thr Leu Ala Ala 12 65 70 75 80 Xle Zle Ala Ser Sin Ala Leu Zle Ser ■ 85 <210> 12 <211> 378 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1)..(378) <400> 12 atg cag gta ttt tta aat att gtc aat aaa ttc ttt gat cca gtt att . 48 Met Gin Val Phe Leu Asn lie Val Asn Lys Phe Phe Asp Pro yal lie 1 5 10 15 cat atg ggt teg gga gtt gtg atg eta att gtc atg aca ggt tta gcc 96 His Met Gly Ser Gly Val Val Met Leu Zle Val Met Thr Gly Leu Ala 20 25 30 atg ata ttt gga gtg aag ttt tct aaa gca ctt gaa ggt ggt att aag ■ 144 Met Zle Phe Gly Val Lys Phe Ser Lys Ala Leu Glu Gly Gly Zle Lys 35 40 45 tta get att get ctt acg ggt att ggt get att att ggt att tta act 192 Leu Ala Zle Ala Leu Thr Gly Zle Gly Ala Zle lie Gly Zle Leu Thr 50 55 60 ggt get ttt tcc gaa tea ctt caa get ttt gtt aaa aat aca gga ate 240 Gly Ala Phe Ser Glu Ser Leu Gin Ala Phe Val Lys Asn Thr Gly zle 65 70 75 80 aat eta age att att gac gtt ggt tgg get cca tta gca act att aca 288 Asn Leu Ser lie Zle Asp Val Gly Trp Ala Pro Leu Ala Thr Zle Thr 85 90 95 tgg gga tea cca tat acg ctt tac ttc tta tta ate atg ctt att gtc 336 Trp Gly Ser Pro Tyr Thr Leu Tyr Phe Leu Leu lie Met Leu Zle Val 100 105 110 aat att gtt atg att gtt atg aaa aaa aaa egg ata cct tag 378 Asn Zle Val Met Zle Val Met Lys Lys Lys Arg lie Pro 115 120 125 13 <210> 13 <211> 125 <212> PRT <213> group B streptococcus <400> 13 Met Gin Val Phe Leu Asn lie Val Asn Lys Phe Phe Asp Pro Val lie 15 10 15 His Met Gly Ser Gly Val Val Met Leu Zle Val Met Thr Gly Leu Ala 20 25 30 Met Zle Phe Gly Val Lys Phe. Ser Lys Ala Leu Glu Gly Gly Zle Lys 35 40 45 Leu Ala lie. Ala Leu-Thr Gly Zle Gly Ala Zle I-le Gly Zle Leu Thr 50 .55 60 Gly Ala Phe Ser Glu Ser Leu Gin Ala Phe Val Lys Asn Thr Gly lie 65 70 75 80 Asn Leu Ser Zle lie Asp Val Gly Trp Ala Pro Leu Ala Thr Zle Thr 85 90 95 Trp Gly Ser Pro Tyr Thr Leu Tyr Phe Leu Leu lie Met Leu lie Val 100 105 110 Asn lie Val Met zle Val Met Lys Lys Lys Arg Zle Pro 115 120 125 <210> 14 <211> 705 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (118)..(705) <400> 14 ggatcgggcg caagcttaac gattcttttt aaaatcatta aattttaaaa caaatttcag 60 acatattgcc aaagttttga tattattact ataatatagt ttgtagagga gaataat 117 14 atg ggc caa gaa cct ate ate gaa tat caa aat ate aat aaa gtg tat 165 Met Gly Gin Glu Pro lie Zle Glu Tyr Gin Asn Zle Asn Lys Val Tyr 15 10 15 ggg gaa aat gtt gcg gtt gaa gat att aac ctt aaa att tac cct ggt 213 Gly Glu Asn Val Ala Val Glu Asp Zle Asn Leu Lys Zle Tyr Pro Gly 20 25 30 gat ttc gtt tgt ttc ate ggt acg agt gga tea ggt aaa aca aca tta 261 Asp Phe Val Cys Phe Zle Gly Thr Ser Gly Ser Gly Lys Thr Thr Leu 35 40 45 atg cgt atg gtt aac cat atg tta aaa cca aca aat ggt act eta tta 309 Met Arg Met Val Asn His Met Leu Lys Pro Thr Asn Gly Thr Leu Leu 50 55 60 ttt aag gga aaa gat ate tct act att aac ccc att gaa tta aga cgc. 357 Phe Lys Gly. Lys-Asp Zle Ser Thr Zle Asn Pro Zle Glu Leu Arg Arg ... 65 70 75 80 aga att gga tat gtt ate caa aac att ggt tta atg cct cat atg acc 405 Arg Zle Gly Tyr Val Zle Gin Asn Zle Gly Leu Met Pro His Met Thr 85 90 95 att tac gaa aat ata gtt ctt gta cca aaa tta ttg aaa tgg tea gaa 453 Zle Tyr Glu Asn Zle Val Leu Val Pro Lys Leu Leu Lys Trp Ser Glu 100 105 110 gaa get aaa aga get aaa gca agg gaa ctt att aaa tta gtt gaa tta 501 Glu Ala Lys Arg Ala Lys Ala Arg Glu Leu Zle Lys Leu Val Glu Leu 115 120 125 cec gaa gaa tat ttg gat cgc tac cct agt gag ttg tct ggc ggt cag 549 Pro Glu Glu Tyr Leu Asp Arg Tyr Pro Ser Glu Leu Ser Gly Gly Gin 130 135 140 caa caa cgt ate ggt gtc att cgc get ctt gca gca gac caa gat att 597 Gin Gin Arg Zle Gly Val Zle Arg Ala Leu Ala Ala Asp Gin Asp Zle 145 150 155 160 att tta atg gat gag cct ttt gga get ctg gat cct att act aga gaa 645 Zle Leu Met Asp Glu Pro Phe Gly Ala Leu Asp Pro Zle Thr Arg Glu 165 170 175 ggt att caa gac ttt agt caa gtc tct tea gga aga aat ggg gga aaa 693 Gly lie Gin Asp Phe Ser Gin Val Ser Ser Gly Arg Asn Gly Gly Lys 180 185 190 15 ota tea tct tag Leu Ser Ser 195 705 <210> 15 <211> 195 <212> PRT <213> group B streptococcus <400> 15 Met Gly Gin Glu Pro Zle Zle Glu Tyr Gin Asn Zle Asn Lys Val Tyr 15 10 15 Gly Glu Asn Val Ala Val Glu Asp Zle Asn Leu Lys lie Tyr Pro Gly 20 25 30 Asp Phe Val Cys Phe lie Gly Thr Ser Gly Ser Gly Lys1 Thr Thr Leu 35 40 45 .Met Arg. Met Val Asn His Met Leu Lys Pro Thr Asn "Gly Thr Leu Leu 50 55 60 ' Phe Lys Gly Lys Asp Zle Ser Thr lie Asn Pro Zle Glu Leu Arg Arg 65 70 75 80 Arg Zle Gly Tyr Val Zle Gin Asn Zle Gly Leu Met Pro His Met Thr 85 90 95 Zle Tyr Glu Asn Zle Val Leu val Pro Lys Leu Leu Lys Trp Ser Glu 100 105 110 Glu Ala Lys Arg Ala Lys Ala Ar§ Glu Leu Zle Lys Leu Val Glu Leu 115 120 125 Pro Glu Glu Tyr Leu Asp Arg Tyr Pro Ser Glu Leu Ser Gly Gly Gin 130 135 140 Gin Gin Arg Zle Gly Val Zle Arg Ala Leu Ala Ala Asp Gin Asp Zle 145 150 155 160 lie Leu Met Asp Glu Pro Phe Gly Ala Leu Asp Pro Zle Thr Arg Glu 165 170 175 Gly lie Gin Asp Phe Ser Gin Val Ser Ser Gly Arg Asn Gly Gly Lys 180 185 190 Leu Ser Ser 16 195 <210> 16 <211> 367 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1)..(366) <400> 16 ate cct tat agt gat gtt ttt get aca gga gga ttt tta tac tat gta 48 lie Pro Tyr Ser Asp Val Phe Ala Thr Gly Gly Phe Leu Tyr Tyr Val 1 5 10 15 acg att get eta agt tac ctt tta ggg tct agt ate tgg tta ttt att 96 Thr lie Ala Leu Ser Tyr Leu Leu Gly Ser Ser I-le Trp Leu Phe Zle

20 . 25 . 30 gta cag ttt att get tac tat gta tct gga att tat ttt tat aaa tta 144 Val Gin Phe Zle Ala Tyr Tyr Val Ser Gly Zle Tyr Phe Tyr Lys Leu 35 40 45 gtt tat tat gtg gca caa agt gaa att gtc teg ata ggc atg acg ttg 192 Val Tyr Tyr- Val Ala Gin Ser Glu lie Val Ser Zle Gly Met Thr Leu 50 55 60 att ttc tat ata atg aat att gtc tta gga ttc ggt ggt atg tac cca 240 He Phe Tyr Zle Met Asn Zle Val Leu Gly Phe Gly Gly Met Tyr Pro 65 70 75 80 ata cag tgg gca tta cct ttt atg ctc att teg eta tgg ttt tta att 288 Zle Gin Trp Ala Leu Pro Phe Met Leu He Ser Leu Trp Phe Leu Zle 85 90 95 aaa ttt tgt gtc gat aat ate gtt gat gaa gca ttt ata ttt tat ggt 336 Lys Phe Cys Val Asp Asn lie Val Asp Glu Ala Phe Zle Phe Tyr Gly 100 105 110 att tta gca gca ttc tea eta ttt ata gat c 367 Zle Leu Ala Ala Phe Ser Leu Phe Zle Asp 115 120 <210> 17 17 <211> 122 <212> PRT <213> group B streptococcus <400> 17 lie Pro Tyr Ser Asp Val Phe Ala Thr Gly Gly Phe Leu Tyr Tyr Val 15 10 15 Thr lie Ala Leu Ser Tyr Leu Leu Gly Ser Ser He Trp Leu Phe lie 20 25 30 Val Gin Phe lie Ala Tyr Tyr Val ser Gly lie Tyr Phe Tyr Lys Leu-35 40 45 Val Tyr Tyr Va! Ala Gin Ser Glu He Val Ser He Gly Met Thr Leu 50 55 60 He Phe Tyr lie Met Asn lie Val Leu Gly Phe Gly Gly Met Tyr .Pro 65 70 75 80 He Gin Trp Ala Leu Pro Phe Met Leu lie Ser' Leu Trp Phe Leu He 85 90 95 Lys Phe Cys Val Asp Asn lie Val Asp Glu Ala Phe lie Phe Tyr Gly 100 105 110 lie Leu Ala Ala Phe Ser Leu Phe He Asp 115 120 <210> 18 <211> 570 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1)..(570) <400> 18 atg agg aaa cgt ttt tcc ttg eta aat ttt att gtt gtt act ttt att 48 Met Arg Lys Arg Phe Ser Leu Leu Asn Phe He Val Val Thr Phe lie 1 5 10 15 ttc ttt ttc ttt att ctt ttt eeg ctt tta aac cat aag gga aaa gta 96 Phe Phe Phe Phe He Leu Phe Pro Leu Leu Asn His Lys Gly Lys Val 20 25 30 18 gat got aat tct agg cag agt gtt acc tac acc aaa gaa gaa ttt: ata 144 Asp Ala Asn Ser Arg Gin Ser Val Thr Tyr Thr I<ys Glu Glu Phe lie 35 40 45 caa aaa att gtg cca gat gcg caa gat eta gga aag teg tac ggt att 192 Gin Lys lie Val Pro Asp Ala Gin Asp Leu Gly Lys Ser Tyr Gly Xle 50 55 60 cgt cct tea ttt att att gca cag gcg get ttg gat tct gat ttc gga 240 Arg Pro ser Phe lie Xle Ala Gin Ala Ala Leu Asp Ser Asp Phe Gly 65 70 75 80 gag aaa tat age tat agt ate ata ate tgt tgg ttg ctt gca gaa cca . 288 Glu Lys Tyr Ser Tyr Ser lie lie He cys Trp Leu Leu Ala G-lu Pro 85 90 95 gga acg ccc tea att acc tta aat gat agt agt aca gga aaa aaa cag 336. Gly Thr Pro Ser He Thr Leu Asn Asp Ser Ser Thr Gly Lys Lys Gin 100 105 110 gaa aag caa ttt act cat tat aaa tet tgg aag tat tea atg gat gat 384 Glu Lys Gin Phe Thr His Tyr Lys Ser Trp Lys Tyr Ser Met Asp Asp 115 120 125 tac ctt get cat ata aaa tct gga gcg aca ggc aaa aaa gat tea tat 432 Tyr Leu Ala His lie Lys Ser Gly Ala Thr Gly Lys Lys Asp Ser Tyr 130 135 140 act ata atg gtg tct gtt aaa aat cca aaa act tta gtg caa aaa tta 480 Thr Xle Met Val Ser Val Lys Asn Pro Lys Thr Leu Val Gin Lys Leu 145 150 155 160 caa gat agt ggt ttt gat aat gac aaa aag tac get aaa aaa atg aeg 528 Gin Asp ser Gly Phe Asp Asn Asp Lys Lys Tyr Ala Lys Lys Met Thr 165 170 175 gaa ate att gat ttg tat gat tta aca aga tat gat aag tga 570 Glu lie lie Asp Leu Tyr Asp Leu Thr Arg Tyr Asp Lys 180 185 190 <210> 19 <211> 189 <212> PRT <213> group B streptococcus <400> 19 19 Het Arg Lys Acg Phe Ser Leu Leu Asn Phe lie Val Val Thr Phe lie 15 10 15 Phe Phe Phe Phe lie Leu Phe Pro Leu Leu Asn His Lys Gly Lys Val 20 25 30 Asp Ala Asn Ser Arg Gin ser Val Thr Tyr Thr Lys Glu Glu Phe lie 35 40 45 Gin Lys He Val pro Asp Ala Gin Asp Leu Gly Lys Ser Tyr Gly lie 50 55 60 Arg Pro Ser Phe lie He Ala Gin Ala Ala Leu Asp Ser Asp Phe Gly 65 70 75 80 Glu Lys Tyr Ser Tyr Ser He He lie cys Trp Leu Leu Ala Glu Pro 85 90 95 Gly Thr Pro Ser He Thr Leu Asn Asp Ser Ser Thr Gly Lys. Lys. .Gin. 100 105 110 , Glu Lys Gin Phe Thr His Tyr Lys ser Trp Lys Tyr Ser Met Asp Asp 115 120 125 Tyr Leu Ala His lie Lys Ser Gly Ala Thr Gly Lys Lys Asp Ser Tyr 130 135 140 Thr He Met Val Ser Val Lys Asn Pro Lys Thr Leu Val Gin Lys Leu 145 150 155 160 Gin Asp Ser Gly Phe Asp Asn Asp Lys Lys Tyr Ala Lys Lys Met Thr 165 170 175 Glu Xle Xle Asp Leu Tyr Asp Leu Thr Aeg Tyr Asp Lys 160 185 <210> 20 <211> 978 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1)..(978) <400> 20 20 atg ctt gtc ate att ttg ate att gta eta get agt ctg aca gtg acg 48 Met Leu Val lie Xle Leu lie Xle Val Leu Ala Ser Leu Thr Val Thr 1 5 10 15 ata att tct tac cca aaa atg acg gaa tta aca aag tcc gtt gaa aaa 96 lie Xle Ser Tyr Pro Lys Met Thr Glu Leu Thr Lys Ser Val Glu Lys 20 25 30 caa ctt gaa gat aat get gat aat eta tea gac caa ctg aca tat cag 144 Gin Leu Glu Asp Asn Ala Asp Asn Leu Ser Asp Gin Leu Thr Tyr Gin 35 40 45 ata gaa gtg gcg caa aaa gat caa ate tac gtg act aat' cag eta aac 192 lie Glu Val Ala Gin Lys Asp Gin lie Tyr Val Thr Asn Gin, Leu.-Asn. . 50 55 60 cgt atg caa cag gaa att ate agt cgc tta ccgata tgc gta.cag aat 240 Arg Met Gin Gin Glu lie Xle ser Arg Leu Pro, lie Cys Val-Glh Asn . 65 . • 70 75 , 80 aaa tea gca tta acg gag agt cga gat cga tea gac aaa. cgc ttg gaa 288 Lys Ser Ala Leu Thr Glu Ser Arg Asp Arg Ser Asp Lys Arg Leu Glu 85 90 95 ttg att aac tcc aat tta tct cag tea gtt cag aaa atg caa gat tea 336 Leu Xle Asn Ser Asn Leu ser Gin Ser Val Gin Lys Met Gin Asp Ser 100 105 110 atg aaa aac get tgg ate aaa tgc gcc aaa ctg ttg agg aaa age tgg 384 Met Lys Asn Ala Trp Xle Lys Cys Ala Lys Leu Leu Arg Lys Ser Trp 115 120 125 aaa aaa cgc tac aaa cgc Lys Lys Arg Tyr Lys Arg 130 caa eta gag age gtc aat Gin Leu Glu Ser Val Asn 145 150 gtt gca aac ttc ttt gaa Val Ala Asn Phe Phe Glu 135 140 caa ggt ctg ggt aga tgg Gin Gly Leu Gly Arg Trp 155 act gta teg cgt 432 Thr Val Ser Arg aaa ctg tgc caa 480 Lys Leu cys Gin 160 gat gtt ggt acc act gaa caa agt ctg tea aat act aag aca agg gga 528 Asp Val Gly Thr Thr Glu Gin Ser Leu Ser Asn Thr Lys Thr Arg Gly 165 170 175 ata tta ggg gag tta caa ctc ggt caa att ata gaa gat att atg aca 576 lie Leu Gly Glu Leu Gin Leu Gly Gin lie Xle Glu Asp lie Met Thr 180 185 190 21 gtt agt caa tat gag aga gaa ttt cct acg gtg tct ggc tct tct gag 624 Val Ser Gin Tyr Glu Arg Glu Phe Pro Thr Val Ser Gly Ser Ser Glu 195 200 205 cgt gtt gaa tat get att aaa tac ctg gaa atg gtc agg gag att ata 672 Arg Val Glu Tyr Ala lie Lys Tyr Leu Glu Met Val Arg Glu lie lie 210 215 220 tct att tgc eta ttg act eta agt ttc tct aga aga tta tta ccg att 720 Ser He Cys Leu Leu Thr Leu Ser Phe Ser Arg Arg Leu Leu Pro lie 225 230 235 240 ggg aga tgc tta tgg aat tgg gtg acc agg ttc aaa tgg aac tct att 768 Gly Arg Cys Leu Trp Asn Trp Val Thr Arg Phe .Lys Trp Asn Ser lie 245 250 255 " cgt. aat ctt tac tgg. gca agt att. cgt aaa ttt gca aaa gat ata aac .: .-816-Arg Asn Leu Tyr Trp. Ala Ser-He Arg Lys Phe Ala Lys Asp He Asn 260 265 270 aat aag tac tta aat . cct cct gaa acg aca aat ttt ggt ate atg ttc"*- - 864 Asn Lys Tyr Leu Asn Pro Pro Glu Thr Thr Asn Phe Gly He Met Phe 275 280 285 tta cca act gaa ggg ctc tat tct gaa gtg gta aga aat gca aca ttc 912 Leu Pro Thr Glu Gly Leu Tyr ser Glu Val Val Arg Asn Ala Thr Phe 290 295 300 ttt gat agt eta aga cgt gac gaa aat att gta gta get gga ccg tea 960 Phe Asp Ser Leu Arg Arg Asp Glu Asn He Val Val Ala Gly Pro Ser 305 310 315 320 acc tta tct get tac taa 978 Thr Leu Ser Ala Tyr 325 <210> 21 <211> 325 <212> PRT <213> group B streptococcus <400> 21 Met Leu Val He lie Leu Zle Zle Val Leu Ala Ser Leu Thr Val Thr 15 10 15 lie Xle. Ser Tyr Pro Lys Met Thr Glu Leu Thr Lys Ser Val Glu Lys 20 25 30 22 Gin Leu Glu Asp Asn Ala Asp Asn Leu Ser Asp Gin Leu Thr Tyr Gin 35 40 45 Xle Glu Val Ala Gin Lys Asp Gin Xle Tyr Val Thr Asn Gin Leu Asn 50 55 60 Arg Met Gin Gin Glu Xle Xle Ser Arg Leu Pro Xle Cys Val Gin Asn 65 70 75 80 Lys Ser Ala Leu Thr Glu ser Arg Asp Arg Ser Asp Lys Arg Leu Glu 85 90 95 Leu lie Asn Ser Asn Leu Ser Gin Ser Val Gin Lys Met Gin Asp Ser 100 105 110 Met Lys Asn Ala Trp Xle Lys Cys Ala Lys Leu. Leu Arg Lys'.Ser. Trp . .115 120 ... 125. '• Lys Lys Arg Tyr Lys Arg val Ala Asn Phe Phe. Glu. Thr. Val Ser. Arg 130 135 140. Gin Leu Glu Ser Val Asn Gin Gly Leu Gly Arg Trp Lys Leu Cys Gin 145 150 155 160 Asp Val Gly Thr Thr Glu Gin Ser Leu Ser Asn Thr Lys Thr Arg Gly 165 170 175 Xle Leu Gly Glu Leu Gin Leu Gly Gin Xle Xle Glu Asp Xle Met Thr 180 185 190 Val Ser Gin Tyr Glu Arg Glu Phe Pro Thr Val Ser Gly ser ser Glu 195 200 205 Arg Val Glu Tyr Ala Xle Lys Tyr Leu Glu Met Val Arg Glu Xle Xle 210 215 220 Ser Xle Cys Leu Leu Thr Leu ser Phe Ser Arg Arg Leu Leu Pro xle 225 230 235 240 Gly Arg Cys Leu Trp Asn Trp Val Thr Arg Phe Lys Trp Asn Ser lie 245 250 255 Arg Asn Leu Tyr Trp Ala Ser Xle Arg Lys Phe Ala Lys Asp lie Asn 260 265 270 Asn Lys Tyr Leu Asn Pro Pro Glu Thr Thr Asn Phe Gly Xle Met Phe 275 280 265 23 Leu Pro The Glu Gly Leu Tyr Ser Glu Val Val Arg Asn Ala Thr Phe 290 295 300 Phe Asp Ser Leu Arg Arg Asp Glu Asn Xle Val Val Ala Gly Pro Ser 305 310 315 320 Thr Leu Ser Ala Tyr 325 <210> 22 <211> 579 <212> DMA <213> group B streptococcus ■ <220> <221> CDS ' <222> (1)..(579) <400> 22 atg cga aaa gaa gtg aca cca gag atg ctt aac tat aat aag tat cct 48 Met Arg Lys Glu Val Thr Pro Glu Met Leu Asn Tyr Asn Lys Tyr Pro 15 10 15 ggc cca cag ttt att cac ttt gaa aat ate gtt aaa agt gat gat att 96 Gly Pro Gin Phe Xle His Phe Glu Asn Xle Val Lys Ser Asp Asp Xle 20 25 30 gaa ttt caa ctt gtt att aat gaa aaa tea get ttt gat gtg act gtc 144 Glu Phe Gin Leu Val Xle Asn Glu Lys Ser Ala Phe Asp Val Thr Val 35 40° 45 ttt gga caa cgt ttt tct gag att tta tta aaa tat gat ttt ate gtt 192 Phe Gly Gin Arg Phe Ser Glu Xle Leu Leu Lys Tyr Asp Phe Xle Val 50 55 60 ggc gat tgg ggt aac gag cag ttg agg eta aga ggc ttt tac aaa gat 240 Gly Asp Trp Gly Asn Glu Gin Leu Arg Leu Arg Gly Phe Tyr Lys Asp 65 70 75 80 get agt acg att aga aaa aat age egg att tea cgt tta gaa gat tat 288 Ala Ser Thr Xle Arg Lys Asn Ser Arg Xle Ser Arg Leu Glu Asp Tyr 85 90 95 att aaa gag tat tgt aac ttt ggt tgt get tat ttt gtg ttg gag aat 336 Xle Lys Glu Tyr Cys Asn Phe Gly Cys Ala Tyr Phe Val Leu Glu Asn 24 100 105 110 cca aat cct aga gat att aaa ttt gat gat gaa aga cct cat aag cgt 384 Pro Asn Pro Arg Asp lie Lys Phe Asp Asp Glu Arg Pro His Lys Arg 115 120 125 cgt aag tea aga tcc aaa tea caa tea tea aag tea caa act aga aat 432 Arg Lys Ser Arg Ser Lys Ser Gin Ser Ser Lys Ser Gin Thr Arg Asn 130 135 140 aat cgt tcc cag tea aat gcc aat get eat ttt aea agt aaa aag cgt 480 Asn Arg Ser Gin Ser Asn Ala Asn Ala His Phe Thr Ser Lys Lys Arg 145 150 155 160 aaa gac aca aaa cgc cgt caa gaa cgt cat att aaa gaa gag caa gat 528 Lys Asp Thr Lys Arg Arg Gin Glu Arg His lie Lys Glu Glu Gin Asp 165 170 175 • aag gaa atg acc tct gca aag cag cat ttg tta ttc gta aga aaa aat 576 Lys Glu Met Thr Ser Ala Lys Gin His Leu Leu Phe Val Arg Lys Asn . 180 185 190 taa 579 <210> 23 <211> 192 <212> PRT <213> group B streptococcus <400> 23 Met Arg Lys Glu Val Thr Pro Glu Met Leu Asn Tyr Asn Lys Tyr Pro 15 10 15 Gly Pro Gin Phe He His Phe Glu Asn He Val Lys Ser Asp Asp lie 20 25 30 Glu Phe Gin Leu Val lie Asn Glu Lys Ser Ala Phe Asp Val Thr Val 35 40 45 Phe Gly Gin Arg Phe Ser Glu lie Leu Leu Lys Tyr Asp Phe lie Val 50 55 60 Gly Asp Trp Gly Asn Glu Gin Leu Arg Leu Arg Gly Phe Tyr Lys Asp 65 70 75 80 Ala Ser Thr lie Arg Lys Asn Ser Arg lie Ser Arg Leu Glu Asp Tyr 25 85 90 95 lie Lys Glu Tyr Cys Asn Phe Gly Cys Ala Tyr Phe Val Leu Glu Asn . 100 105 110 Pro Asn Pro Arg Asp Xle Lys Phe Asp Asp Glu Arg Pro His Lys Arg 115 120 125 Arg Lys Ser Arg Ser Lys Ser Gin Ser Ser Lys Ser Gin Thr Arg Asn 130 135 140 Asn Arg Ser Gin Ser Asn Ala Asn Ala His Pbe Thr Ser Lys Lys Arg 145 150 155 160 Lys Asp Thr Lys Arg Arg Gin Glu Arg His Xle Lys Glu Glu Gin Asp 165 170 . 175 Lys Glu Met Thr Ser Ala Lys Gin His Leu Leti Phe Val Arg Lys Asn-180 185 190 <210> 24 <211> 609 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1) . . (609) <400> 24 atg aca ata aaa aaa gtg tta agt gta aca gga att att tta gtg aca 48 Met Thr lie Lys Lys Val Leu Ser Val Thr Gly lie lie Leu Val Thr 15 10 15 gta gcg tct eta get get tgt age tea aaa tet cat act act aag acg 96 Val Ala Ser Leu Ala Ala Cys Ser Ser Lys Ser His Thr Thr Lys Thr 20 25 30 ggc aaa aaa gaa gtt aat ttt gca act gtt gga aca acg gca cct ttt 144 Gly Lys Lys Glu Val Asn Phe Ala Thr Val Gly Thr Thr Ala pro Phe 35 40 45 tct tat gtg aag gat ggg aaa ctg act ggc ttt gat att gaa gta gcc 192 Ser Tyr Val Lys Asp Gly Lys Leu Thr Gly Phe Asp lie Glu Val Ala 50 55 60 26 aaa get gtt ttt aaa ggt tea gat aac tat aaa gtc act ttt aaa aaa 240 Lys Ala Val Phe Lys Gly Ser Asp Asn Tyr Lys Val Thr Phe Lys Lys 65 70 75 80 aca gaa tgg tea teg gta ttt acc ggc att gat tea gga aag ttt caa 286 Thr Glu Trp Ser Ser Val Phe Thr Gly lie Asp Ser Gly Lys Phe Gin 85 90 95 atg ggt gga aat aat att tct tat tea tea gag aga tct caa aaa tay 336 Met Gly Gly Asn Asn lie Ser Tyr Ser Ser Glu Arg Ser Gin Lys Tyr 100 105 110 tta ttt tea tac cea ata ggc tct act cct tea gtt tta gca gtt cot 384 Leu Phe ser Tyr Pro lie Gly Ser Thr Pro Ser Val Leu Ala Val Pro . 115 120 125 aag aat agt aat ate aaa get tat aat gat att agt ggt cat aaa aca 432 Lys Asn Ser Asn He Lys Ala Tyr Asn Asp lie Ser Gly His Lys Thr 130 135 140 cag gtt gtc caa gga acg aca act gcc aag caa tta gaa aat ttc aat 480 Gin Val Val Gin Gly Thr Thr Thr Ala Lys Gin Leu Glu Asn Phe Asn 145 150 155 160 aaa gag cat cag aaa aat cct gtt act eta aaa tat act aat gaa aat 528 Lys Glu His Gin Lys Asn Pro Val Thr Leu Lys Tyr Thr Asn Glu Ash 165 170 175 att aca cag att eta acg aat ttg agt gat gga aaa get gat ttt aaa 576 He Thr Gin He Leu Thr Asn Leu Ser Asp Gly Lys Ala Asp Phe Lys 180 185 190 ctt ttg acg gac caa ctg tta acg eta tta taa 609 Leu Leu Thr Asp Gin Leu Leu Thr Leu Leu 195 200 <210> 25 <211> 202 <212> PRT <213> group B streptococcus <400> 25 Met Thr lie Lys Lys Val Leu Ser Val Thr Gly lie lie Leu Val Thr 1 5 10 15 Val Ala Ser Leu Ala Ala Cys Ser Ser Lys Ser His Thr Thr Lys Thr 20 25 30 27 Sly Lys Lys Glu Val Asn Phe Ala Thr Val Gly Thr Thr Ala Pro Phe 35 40 45 Ser Tyr Val Lys Asp Gly Lys Leu Thr Gly Phe Asp lie Glu Val Ala 50 55 60 Lys Ala Val Phe Lys Gly Ser Asp Asn Tyr Lys Val Thr Phe Lys Lys 65 70 75 80 Thr Glu Trp Ser Ser Val Phe Thr Gly lie Asp Ser Gly Lys Phe Gin 85 90 95 Met Gly Gly Asn Asn lie Ser Tyr Ser Ser Glu Arg Ser Gin Lys Tyr 100 105 110 Leu . Phe Ser Tyr Pro . He Gly Ser Thr Pro Ser Val Leu Ala Val -Pro 115 120 125 Lys Asn Ser Asn lie Lys Ala Tyr Asn Asp He Ser Gly His Lys Thr . 130 135 140 Gin Val Val Gin Gly Thr Thr Thr Ala Lys Gin Leu Glu Asn Phe Asn 145 150 155 160 Lys Glu His Gin Lys Asn Pro Val Thr Leu Lys Tyr Thr Asn Glu Asn 165 170 175 Xle Thr Gin Xle Leu Thr Asn Leu Ser Asp Gly Lys Ala Asp Phe Lys 180 185 190 Leu Leu Thr Asp Gin Leu Leu Thr Leu Leu 195 200 • <210> 26 <211> 357 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1)..(357) <400> 26 atg aag aat ata aca aag eta tea act gtt get tta age eta eta ctt Met Lys Asn Xle Thr Lys Leu Ser Thr Val Ala Leu Ser Leu Leu Leu 28 15 10 15 tgt acg gcg tgt get gca tea aac acg tct aca tct aaa aca cag tct 96 Cys Thr Ala Cys Ala Ala Ser Asn Thr Ser Thr Ser Lys Thr Gin Ser 20 25 30 cat cat cct aaa caa act aaa ctc aca gat aag caa aaa gaa gaa cec 144 His His Pro Lys Gin Thr Lys Leu Thr Asp Lys Gin Lys Glu Glu Pro 35 40 45 aaa aac aaa gaa get get gat caa gag atg cat ccc caa ggc get gtt 192 l>ys Asn Lys Glu Ala Ala Asp Gin Glu Het His Pro Gin Gly Ala Val 50 55 60 gat ttg aca aaa tat aag gca aaa ccg gtc aaa gat tat gga aaa aaa 240 Asp leu Thr Lys Tyr Lys Ala Lys Pro Val Lys'Asp Tyr Gly Lys Lys • 65 70 75 80 ate gat gtt ggt gat ggc aag aaa atg aac att tat gaa act ggt cag 288 lie Asp Val Gly Asp Gly Lys Lys Met Asn lie Tyr Glu Thr Gly Gin '' 85 90 95 gga aaa att cca att gtt ttt att cct ggt caa get gag att cgc cac 336 Gly Lys He Pro He Val Phe He Pro Gly Gin Ala Glu He Arg His 100 105 110 get atg ctt ata aga att taa 357 Ala Met Leu lie Arg He 115 <210> 27 <211> 118 <212> PRT <213> group B streptococcus <400> 27 Met Lys Asn He Thr lys leu Ser Thr Val Ala Leu Ser Leu leu Leu 15 10 15 Cys Thr Ala Cys Ala Ala Ser Asn Thr Ser Thr Ser Lys Thr Gin Ser 20 25 30 His His Pro Lys Gin Thr Lys Leu Thr Asp Lys Gin Lys Glu Glu Pro 35 40 45 Lys Asn Lys Glu Ala Ala Asp Gin Glu Met His Pro Gin Gly Ala Val 50 55 60 29 Asp Leu Thr Lys Tyr Lys Ala Lys Pro Val Lys Asp Tyr Gly Lys Lys 65 70 75 80 lie Asp Val Gly Asp Gly Lys Lys Met Asn lie Tyr Glu Thr Gly Gin 85 90 95 Gly Lys lie Pro Zle Val Phe lie Pro Gly Gin Ala Glu Zle Arg His 100 105 110 Ala Met Leu Zle Arg Zle 115 <210> 28 <211> 1191 <212> DNA <213> grpup B streptococcus <220> <221> CDS <222> (1)..(1191) <400> 28 gtg aat gaa teg acc ate aga aaa gaa ttt aaa ata gtt gtt ttt aaa 48 Val Asn Glu Ser Thr lie Arg Lys Glu Phe Lys Zle Val Val Phe Lys 1 5 10 15 tgg ate tta aat aat caa gca gtt att get ctc atg att acc ttt ttg 96 Trp Zle Leu Asn Asn Gin Ala Val lie Ala Leu Met Zle Thr Phe Leu 20 25 30 gta ttt tta aeg att ttt att ttt acc aaa ate tct ttt atg ttt aaa 144 Val Phe Leu Thr Zle Phe Zle Phe Thr Lys Zle Ser Phe Met Phe Lys 35 40 45 cct gtg ttt gat ttt ctt get gtg ctg ata ttg ccg ctt gta att tct 192 Pro Val Phe Asp Phe Leu Ala Val Leu Zle Leu Pro Leu Val Zle Ser 50 55 60 ggc ttg ctt tat tac eta tta aaa cct atg gtt aca ttt tta gag aag 240 Gly Leu Leu Tyr Tyr Leu Leu Lys Pxro Met Val Thr Phe Leu Glu Lys 65 70 75 80 egg gga att aag cgt gta aca gcg ata tta tea gtt ttt act att ata 288 Arg Gly Zle Lys Arg Val Thr Ala Zle Leu Ser Val Phe Thr Zle lie 85 90 95 30 1 v«nv r vrW ate ctt ctg tta att tgg gca atg tct agt ttt att ccc atg atg agt 336 lie Leu Leu Leu lie Trp Ala Met Ser Ser Phe lie Pro Met Met Ser 100 105 110 aat caa tta cgc cat ttt atg gaa gat ctc cct tea tat gtg aat aaa 384 Asn 6ln Leu Arg His Phe Met Glu Asp Leu Pro Ser Tyr Val Asn Lys 115 120 125 gtg caa atg gaa aca agt teg ttt ata gat cac aac cct tgg tta aaa 432 Val Gin Met Glu Thr Ser Ser Phe He Asp His Asn Pro Trp Leu Lys 130 135 140 tct tat aaa ggg gaa ata teg age atg tta tct aat ate agt age. caa 480 . Ser Tyr Lys Gly Glu lie Ser Ser Met Leu Ser Asn He Ser Ser -Gin 145 150 155 160 gcg gtc tct tat get gaa aaa ttt tea Ala Val Ser Tyr Ala Glu Lys Phe Ser 165 aag aat gtt tta gat tgg. gca 528 Lys Asn- Val Leu Asp Trp Ala 170 175 gga aat tta get agt aca gtt gca cgt gtg aca gta gca aca ate atg 576 Gly Asn Leu Ala Ser Thr Val Ala Arg Val Thr Val Ala Thr lie Met 180 185 190 get ccc ttt att ttg ttt tat ctt tta aga gat agt cgc aac atg aag 624 Ala Pro Phe lie Leu Phe Tyr Leu Leu Arg Asp Ser Arg Asn Met Lys 195 200 205 aat ggt ttc tta atg gtt tta cca acc aaa eta cgc caa cca get gat 672 Asn Gly Phe Leu Met Val Leu Pro Thr Lys Leu Arg Gin Pro Ala Asp 210 215 220 cgt att ttg cga gaa atg aat agt caa atg tea gga tat gtg caa gga 720 Arg He Leu Arg Glu Met Asn Ser Gin Met Ser Gly Tyr Val Gin Gly 225 230 235 1240 caa ate att gtt get att act gtt ggt gtt att ttt tea ata atg tat 768 Gin lie He Val Ala He Thr Val Gly Val He Phe Ser lie Met Tyr 245 250 255 agt att ata ggc ctt aga tat ggc gtg aca tta ggg att att gcc ggt 816 Ser Xle He Gly Leu Arg Tyr Gly Val Thr Leu Gly Xle Xle Ala Gly 260 265 270 gtg tta aat atg gtt ccc tat ttg gga agt ttt gtc gcc caa att cca 864 Val Leu Asn Met Val Pro Tyr Leu Gly Ser Phe Val Ala Gin lie Pro 275 280 285 31 gtg ttt ate tta gcg ctt gtc gca gga cct gtt atg gtt gtt aaa gtt 912 Val Pbe lie Leu Ala Leu Val Ala Gly Pro Val Met Val Val Lys Val 290 295 300 gcg att gtt ttt gtt att gag caa act eta gag gga cgc ttt gtc tea 960 Ala lie Val Phe Val lie Glu Gin Thr Leu Glu Gly Arg Phe Val ser 305 310 315 320 cct ttg gtt tta ggt aat aaa ctt age att cat cca att aca att atg 1008 Pro Leu Val Leu Gly Asn Lys Leu Ser He His Pro He Thr lie Met 32S 330 335 ttt att tta tta acc tct gga gcg atg ttt ggt gtt tgg gga gta ttc 1056 Phe He Leu Leu Thr Ser Gly Ala Met Phe Gly Val Trp Gly Val Phe 340 345 350 ctc agt att ccg att tat gca tct ate aaa gtt gtt gtt aaa gaa ttg 1104 Leu Ser lie Pro lie Tyr Ala ser lie Lys Val Val Val Lys. Glu Leu 355 360 365 ttt gat tgg tac aaa get gtc agt ggg eta tat aca ata gat gtt gtt 1152 Phe Asp Trp Tyr Lys Ala Val ser Gly Leu Tyr Thr lie Asp Val Val 370 375 380 act gaa gaa aga agt gaa gaa gtt aaa aat gtt gaa tag 1191 Thr Glu Glu Arg Ser Glu Glu Val Lys Asn Val Glu 385 390 395 <210> 29 <211> 396 <212> PRT <213> group B streptococcus <400> 29 Val Asn Glu Ser Thr lie Arg Lys Glu Phe Lys lie Val Val Phe Lys 15 10 15 Trp Xle Leu Asn Asn Gin Ala Val lie Ala Leu Met Xle Thr Phe Leu 20 25 30 Val Phe Leu Thr lie Phe lie Phe Thr Lys lie Ser Phe Met Phe Lys 35 40 45 Pro Val Phe Asp Phe Leu Ala Val Leu lie Leu Pro Leu Val Xle Ser 50 55 60 32 Gly Leu Leu Tyr Tyr Leu Leu Lys pro Met Val Thr Phe Leu Glu Lys 65 70 75 80 Arg Gly He Lys Arg Val Thr Ala Zle I^eu Ser Val Phe Thr Zle Zle 85 -*0 95 lie Leu Leu Leu Zle Trp Ala Met Ser Ser Phe Zle Pro Met Met ser 100 105 110 Asn Gin Leu Arg His Phe Met Glu Asp Leu Pro Ser Tyr Val Asn Lys 115 120 125 Val Gin Met Glu Thr Ser Ser Phe Zle Asp His Asn Pro Trp Leu Lys 130 135 140 Ser Tyr Lys Gly Glu lie ser Ser Met Leu ser Asn Zle Ser ser Gin 145 150 155 160 Ala Val Ser Tyr Ala Glu Lys Phe Ser Lys Asn Val Leu Asp Trp Ala 165 170 175 Gly Asn Leu Ala Ser Thr Val Ala Arg Val Thr Val Ala Thr lie Met 180 185 190 Ala Pro Phe Zle Leu Phe Tyr Leu Leu Arg Asp Ser Arg Asn Met Lys 195 200 205 Asn Gly Phe Leu Met Val Leu Pro Thr Lys Leu Arg Gin Pro Ala Asp 210 215 220 Arg Zle Leu Arg Glu Met Asn Ser Gin Met Ser Gly Tyr Val Gin Gly 225 230 235 240 Gin Zle Zle Val Ala Xle Thr Val Gly Val Zle Phe Ser Zle Met Tyr 245 250 255 Ser Xle Xle Gly Leu Arg Tyr Gly Val Thr Leu Gly lie Xle Ala Gly 260 265 270 Val Leu Asn Met Val Pro Tyr Leu Gly Ser Phe Val Ala Gin lie Pro 275 280 285 Val Phe Xle Leu Ala Leu Val Ala Gly Pro Val Met Val Val Lys Val 290 295 300 Ala Xle Val Phe Val Xle Glu Gin Thr Leu Glu Gly Arg Phe Val Ser 305 310 315 320 33 Pro Leu Val Leu Gly Asn Lys Leu Ser lie His Pro lie Thr He Met 325 330 335 Phe lie Leu Leu Thr Ser Gly Ala Met Phe Gly Val Trp Gly Val Phe 340 345 350 Leu Ser lie Pro He Tyr Ala Ser lie Lys Val Val Val Lys Glu Leu 355 360 365 Phe Asp Trp Tyr Lys Ala Val Ser Gly Leu Tyr Thr lie Asp Val Val 370 375 380 Thr Glu Glu Arg Ser Glu Glu Val Lys Asn Val Glu 385 390 395 <210> 30 <211> 1230 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1) . . (1230) <400> 30 atg ttt atg gga ate cca caa tat ttc ttc tac ctt ate tta get gtc 48 Met Phe Met Gly lie Pro Gin Tyr Phe Phe Tyr. Leu lie Leu Ala Val 15 10 15 eta cca att tac ate ggc tta ttc ttt aag aag cgt ttt gcc tta tat 96 Leu Pro Zle Tyr Zle Gly Leu Phe Phe Lys Lys Arg Phe Ala Leu Tyr 20 25 30 gag att att ttt agt eta agt ttt att gta atg atg ttg act ggt agt 144 Glu Zle Zle Phe Ser Leu Ser Phe Zle Val Met Met Leu Thr Gly Ser 35 40 45 act ttt aat caa ttg aag tea eta ttg gca tac gtt gtc gga cag tct 192 Thr Phe Asn Gin Leu Lys Ser Leu Leu Ala Tyr Val Val Gly Gin Ser 50 55 60 ctg eta gtt ttt ate tat aaa get tac egg aaa cga ttt aat cat act 240 Leu Leu Val Phe zle Tyr Lys Ala Tyr Arg Lys Arg Phe Asn His Thr 65 70 75 80 ttg gtc ttt tat gta aeg gtt tgt tta tct att ttt ccg eta ttt ttg 288 34 Leu Val Phe Tyr Val Thr Val Cys Leu Ser Zle Phe Pro Leu Phe Leu 85 90 95 gta aaa tta att cca get ata tct gag gat ggg cat cag tea ctt ttt 336 Val I»ys Leu Zle Pro Ala Zle Ser Glu Asp Gly His Gin Ser Leu Phe 100 105 110 ggg ttt eta gga att tct tac ctt act ttt aga get gtt get atg att 384 Gly Phe Leu Gly Zle Ser Tyr Leu Thr Phe Arg Ala Val Ala Met Zle 115 120 125 att gaa atg aga gac ggt gtc ttg aaa gaa ttt act tta tgg gaa ttc 432 Xle Glu Met Arg Asp Gly Val Leu Lys Glu Phe Thr Leu Trp Glu Phe 130 135 140 tta aga ttt tta ctc ttc ttt cca act ttc tea agt gga cca att gat 460 Leu Arg Phe Leu Leu Phe Phe Pro Thr Phe Ser ser Gly Pro lie Asp . 145 150 155. * i60 cgt ttt aaa cga ttc aat gag gat tac att aat ate cca gat ega'-aac' - 528 Arg Phe Lys Arg Phe Asn Glu Asp Tyr Zle Asn Zle Pro Asp Arg Asn ' 165 170 175 gaa ctc eta gat atg tta ggt caa gcg att cat tat ttg atg tta ggt 576 Glu Leu Leu Asp Met Leu Gly Gin Ala Zle His Tyr Leu Met Leu Gly 180 185 190 ttt ctc tat aag ttt att tta gcc tat att ttt gga agt ctg att atg 624 Phe Leu Tyr Lys Phe Xle Leu Ala Tyr Xle Phe Gly Ser Leu Xle Met 195 200 205 cct cct eta aaa gaa tta gcg eta gaa cag ggt ggt gtg ttt aat tgg 672 Pro Pro Leu Lys Glu Leu Ala Leu Glu Gin Gly Gly Val Phe Asn Trp 210 215 220 cca aca ctt ggg gtt atg tat gcc ttt ggt ttt gat ttg ttc ttt gat 720 Pro Thr Leu Gly Val Met Tyr Ala Phe Gly Phe Asp Leu Phe Phe Asp 225 230 235 240 ttt gca ggt tac aca atg ttt gcg ttg get att tct aac eta atg ggg 768 Phe Ala Gly Tyr Thr Met Phe Ala Leu Ala Zle Ser Asn Leti Met Gly 245 250 255 att aag tct ccg att aac ttt gac aaa cct ttc aaa tea cgc gac eta 816 Xle Lys Ser Pro lie Asn Phe Asp Lys Pro Phe Lys Ser Arg Asp Leu 260 265 270 aaa gaa ttt tgg aat aga tgg cat atg age ctt tct ttc tgg ttt aga 864 35 Lys Glu Phe Trp Asn Arg Trp His Met Ser Leu Ser Phe Trp Phe Arg 275 280 285 gac ttt gtt ttc atg agg ctt gtt aag ctt tta gtt aaa aat aaa gtt 912 Asp Phe Val Phe Met Arg Leu Val Lys Leu Leu Val Lys Asn Lys Val 290 295 300 ttt aaa aac cgt aat gtt act tea agt gta get tat att ate aat atg 960 Phe Lys Asn Arg Asn Val Thr Ser Ser Val Ala Tyr lie Xle Asn Met 305 310 315 320 ctt ctt atg gga ttc tgg cat ggg tta act tgg tac tat ata gee tat 1008 Leu Leu Met Gly Phe Trp His Gly Leu Thr Trp Tyr Tyr lie Ala Tyr 325 330 335 ggt ctc ttt cat ggg att ggc eta gtt "att aat gac get tgg gta cgt 1056 Gly Leu Phe His-Gly lie Gly Leu Val lie Asn Asp Ala Trp Val Arg' 1 . 340 345 350 aag aag aaa aat ayt aat aaa gaa aga aga ttg get aaa aaa cca ett -1104 Lys Lys Lys Asn Xaa Asn Lys Glu Arg Arg Leu Ala Lys Lys Pro Leii 355 360 365 tta cca gaa aac aaa tgg act tat get ttg ggt gtc ttc ate acc ttt 1152-Leu Pro Glu Asn Lys Trp Thr Tyr Ala Leu Gly Val Phe lie Thr Phe 370 375 380 aat gta gtt atg ttt tct ttc ttg att ttt tea gga ttt tta gat ett 1200 Asn Val Val Met Phe Ser Phe Leu Zle Phe Ser Gly Phe Leu Asp Leu 385 390 395 400 ttg tgg ttc cca caa ccg cat aac aaa taa 1230 Leu Trp Phe Pro Gin Pro His Asn Lys 405 410 <210> 31 <211> 409 <212> PRT <213> group B streptococcus <400> 31 Met Phe Met Gly Zle Pro Gin Tyr Phe Phe Tyr Leu Zle Leu Ala Val 15 10 15 Leu Pro Zle Tyr Zle Gly Leu Phe Phe Lys Lys Arg Phe Ala Leu Tyr 20 25 30 36 Glu Xle lie Phe Ser Leu Ser Phe lie Val Met Met Leu Thr Gly Ser 35 40 45 Thr Phe Asn Gin Leu Lys Ser Leu Leu Ala Tyr Val Val Gly Gin Ser 50 55 60 Leu Leu Val Phe lie Tyr Lys Ala Tyr Arg Lys Arg Phe Asn His Thr 65 70 75 80 Leu Val Phe Tyr Val Thr Val Cys Leu Ser lie Phe Pro Leu Phe Leu 85 90 95 Val Lys Leu He Pro Ala lie Ser Glu Asp Gly His Gin ser Lieu Phe 100 105 110 Gly Phe Leu Gly lie Ser Tyr Leu Thr Phe Arg-Ala Val Ala Met He 115 120 125 lie Glu Met Arg Asp Gly Val Leu Lys Glu Phe Thr Leu Trp Glu Phe 130 . .135 140 Leu Arg Phe Leu Leu Phe Phe Pro Thr Phe Ser Ser Gly Pro He Asp 145 150 155 160 Arg Phe Lys Arg Phe Asn Glu Asp Tyr lie Asn lie Pro Asp Arg Asn 165 170 175 Glu Leu Leu Asp Met Leu Gly Gin Ala lie His Tyr Leu Met Leu Gly 180 185 190 Phe Leu Tyr Lys Phe He Leu Ala Tyr lie Phe Gly Ser Leu He Met 195 200 205 Pro Pro Leu Lys Glu Leu Ala Leu Glu Gin Gly Gly Val Phe Asn Trp 210 215 220 Pro Thr Leu Gly Val Met Tyr Ala Phe Gly Phe Asp Leu Phe phe Asp 225 230 235 240 Phe Ala Gly Tyr Thr Met Phe Ala Leu Ala lie Ser Asn Leu Met Gly 245 250 255 lie Lys Ser Pro lie Asn Phe Asp Lys Pro Phe Lys Ser Arg Asp Leu 260 265 270 Lys Glu Phe Trp Asn Arg Trp His Met Ser Leu Ser Phe Trp Phe Arg 275 280 285 37 Asp Phe Val Phe Met Arg Leu Val Lys Leu Leu Val Lys Asn Lys Val 290 295 300 Phe Lys Asn Arg Asn Val Thr Ser Ser Val Ala Tyr lie lie Asn Met 305 310 315 320 Leu Leu Met Gly Phe Trp His Gly Leu Thr Trp Tyr Tyr Xle Ala Tyr 325 330 335 Gly Leu Phe His Gly lie Gly Leu Val He Asn Asp Ala Trp Val Arg 340 345 350 Lys Lys Lys Asn Xaa Asn Lys Glu Arg Arg Leu Ala Lys Lys Pro Leu 355 360 365 Leu Pro Glu Asn Lys Trp Thr Tyr Ala Leu Gly Val . Phe' I-le Thr Phe 370 375 380 Asn Val Val Met Phe Ser Phe Leu He Phe Ser Gly Phe' Leu Asp Leu 385 390 395 * 400 Leu Trp Phe Pro Gin Pro His Asn Lys 405 <210> 32 <211> 100 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1)..(99) <400> 32 atg aat aaa ata acg aca tta tea acc Met Asn Lys lie Thr Thr Leu Ser Thr 1 5 ate gcc ctg act tta atg ctt 48 He Ala Leu Thr Leu Met Leu 10 15 tgc gtt gga tgt tct gcc aat aaa gat aat caa aaa act aaa act gag 96 Cys Val Gly Cys Ser Ala Asn Lys Asp Asn Gin Lys Thr Lys Thr Glu 20 25 30 gat c 100 Asp 38 WO 00/37646 PCT/GB99/04377 <210> 33 <211> 33 <212> PRT <213> group B streptococcus <400> 33 Het Asn Lys lie Thr Thr Leu Ser Thr lie Ala Leu Thr Leu Met Leu 15 10 15 Cys Val Gly Cys Ser Ala Asn Lys Asp Asn Gin Lys Thr Lys Thr Glu 20 25 30 Asp <210> 34 <211> 654 <212> DNA <213> group B streptococcus <220> <221> CDS <222> (1)..(654) <400> 34 gat cga ggc tat caa gaa gca atg get aaa eta agg aaa act tac ggc 48 Asp Arg Gly Tyr Gin Glu Ala Met Ala Lys Leu Arg Lys Thr Tyr Gly 15 10 15 gaa tat ggt tta ggg gtt tct aca gga tta gat tta cct gaa tea gaa 96 Glu Tyr Gly Leu Gly Val Ser Thr Gly Leu Asp Leu Pro Glu Ser Glu 20 25 30 ggt tat gta cct gga aaa tac age tta gga aca act eta atg gaa teg 144 Gly Tyr Val Pro Gly Lys Tyr Ser Leu Gly Thr Thr Leu Met Glu Ser 35 40 45 ttc ggt cag tat gat gcc tat aca cca atg caa ctt ggt cag tat ate 192 Phe Gly Gin Tyr Asp Ala Tyr Thr Pro Met Gin Leu Gly Gin Tyr lie 50 55 60 tea act att gcg aat aat ggg aat cgt tta gca cct cac gtg gtt tea 240 Ser Thr He Ala Asn Asn Gly Asn Arg Leu Ala Pro His Val Val Ser 65 70 75 80 gat ate tat gaa ggg aat gat tct aat aag ttc get caa ttg gtt cgt 288 39 WO 00/37646 PCT/GB99/04377 Asp lie Tyr Glu Gly Asn Asp Ser Asn Lys Phe Ala Gin Leu Val Arg 85 90 95 tea ate act cct aaa aca eta aat aag ata get ate tea gat caa gag 336 Ser lie Thr Pro Lys Thr Leu Asn Lys Zle Ala lie Ser Asp Gin Glu 100 105 110 tta gee att att caa gaa ggt ttt tat aac gtt gtc aat agt gga agt 384 Leu Ala lie Zle Gin Glu Gly Phe Tyr Asn Val Val Asn Ser Gly Ser 115 120 125 ggc tat gca act ggt acg tea atg agg ggg aat gtg aca acc att agy 432 Gly Tyr Ala Thr Gly Thr Ser Met Arg Gly Asn Val Thr Thr Zle Xaa 130 135 140 ggt aaa act ggt acc get gaa aca ttt get aaa aat ata a!at. gga caa 480 Gly Lys Thr Gly Thr Ala Glu Thr Phe Ala Lys Asn Zle Asn- Gly Gin 145 150 155 160 aea gtt tct acc tac aac tta aac get att gcc tac gat act aat cgt 528 Thr Val Ser Thr Tyr Asn Leu Asn Ala Zle Ala Tyr Asp Thr- Asn Arg 165 170 175 aaa ata gca gta gcg gta atg tat ccg cat gtt aca act gat aca aca 576 Lys Zle Ala Val Ala Val Met Tyr Pro His Val Thr Thr Asp Thr Thr 180 185 190 aaa tcc cat caa tta gtt gca cga gat atg att gat caa tat att tea 624 Lys Ser His Gin Leu val Ala Arg Asp Met Zle Asp Gin Tyr Zle Ser 195 200 205 cag tea cag gac aat aag aga gga cat tga 654 Gin Ser Gin Asp Asn Lys Arg Gly His 210 215 <210> 35 <211> 217 <212> PRT <213> group B streptococcus <400> 35 Asp Arg Gly Tyr Gin Glu Ala Met Ala Lys Leu Arg Lys Thr Tyr Gly 1 5 10 15 Glu Tyr Gly Leu Gly Val ser Thr Gly Leu Asp Leu Pro Glu Ser Glu 20 25 30 40 54 39 2 Gly Tyr Val Pro Gly Lys Tyr Ser Leu Gly Thr Thr Leu Met Glu Ser 35 40 45 "the "Sly Gin Tyr Asp Ala Tyr Thr Pro Met Gin Leu Gly Gin Tyr lie 50 55 60 Ser Thr Xle Ala Asn Asn Gly Asn Arg Leu Ala Pro His Val Val Ser 65 70 75 80 Asp Xle Tyr Glu Gly Asn Asp Ser Asn Lys Phe Ala Gin Leu val Arg 85 90 95 Ser Xle Thr Pro Lys Thr Leu Asn Lys Xle Ala' Xle Ser Asp Gin Glu 100 105 110 Leu Ala Xle lie Gin Glu Gly Phe Tyr Asn Val-Val Asn Ser Gly Ser 115 120 . 125 Gly Tyr Ala Thr Gly Thr Ser Met Arg Gly Asn Val . Thr Thr lie Xaa 130 135 140 Gly Lys Thr Gly Thr Ala Glu Thr Phe Ala Lys Asn Xle Asn Gly Gin 145 150 155 160 Thr Val Ser Thr Tyr Asn Leu Asn Ala lie Ala Tyr Asp Thr Asn Arg 165 170 175 Lys Xle Ala Val Ala Val Met Tyr Pro His Val Thr Thr Asp Thr Thr 180 185 190 Lys Ser His Gin Leu Val Ala Arg Asp Met Xle Asp Gin Tyr Xle Ser 195 200 205 Gin Ser Gin Asp Asn Lys Arg Gly His 210 215 41